#cancersm Transcript

Healthcare social media transcript of the #cancersm hashtag.
().
See #cancersm Influencers/Analytics.

ProfileTweet
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectives from our own cancer communities. Our topic is “Basics of Biomarker Testing”
Christina Lizaso @btrfly12
RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv…
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv…
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv…
@LungCancerFaces
RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv…
Jamie Holloway, PhD @jamienholloway
Ready for tonight's chat: Basics of Biomarker Testing! #cancersm
Liz Salmi @TheLizArmy
RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
I’m your moderator, Tim Allen (@timallenmdjd) Pulmonary pathologist. Professor and Chair of the Department of Pathology at the University of Mississippi Medical Center @UMMCnews @UMMC_Pathology in Jackson, Mississippi #cancersm
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
#Myeloma peeps join in tonight's #cancersm chat #MMSM
Bob Steele @steele_bob
Good evening folks. Bob here from Greensboro, NC. #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/qcE5TUfeLp
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
RT @jamienholloway: Ready for tonight's chat: Basics of Biomarker Testing! #cancersm https://t.co/AoqVfpTcZw
Christina Lizaso @btrfly12
RT @TimAllenMDJD: More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/qcE5TUfeLp
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Please remember to include #cancersm in ALL your tweets so the other chat participants can see them. If you are new to Twitter, or need a refresher, please read the #LCSM primer on participating in a Twitter chat -https://t.co/shziI4sXdT
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
We'll get started in a few minutes -- please take a moment to introduce yourselves. #cancersm
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @TimAllenMDJD: More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/qcE5TUfeLp
Janet Freeman-Daily @JFreemanDaily
Hi everyone! Welcome to the pancancer #CANCERSM chat on "Basics of Biomarkers Testing"! Remember to us #cancersm instead of other cancer hashtags (like #LCSM #BCSM #BTSM @GYCSM etc.)
#LCSM Chat @lcsmchat
Deana Hendrickson @LungCancerFaces in Los Angeles here. Calling all #lcsm lung cancer people to tonight’s #CANCERSM Chat on biomarkers.
Israh Akhtar Khan @israhkhan
RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv…
yetAnotherName @glostaMAssachu
Hello all! Betsy from Gloucester, MA here #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @LungCancerFaces: Remember #LCSM friends, for tonight’s chat we will use the #CANCERSM hashtag! https://t.co/pesMIAior5
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
Good evening, Matt Katz, radiation oncologist joining from Massachusetts. I hope everyone is well, looking forward to #cancersm
Janet Freeman-Daily @JFreemanDaily
RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv…
Christina Lizaso @btrfly12
RT @TimAllenMDJD: Please remember to include #cancersm in ALL your tweets so the other chat participants can see them. If you are new to Tw…
Janet Freeman-Daily @JFreemanDaily
RT @jamienholloway: Ready for tonight's chat: Basics of Biomarker Testing! #cancersm https://t.co/AoqVfpTcZw
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/qcE5TUfeLp
Jamie Holloway, PhD @jamienholloway
I'm Jamie-- cancer scientist and advocate in the DC area. #cancersm
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: Please remember to include #cancersm in ALL your tweets so the other chat participants can see them. If you are new to Tw…
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: We'll get started in a few minutes -- please take a moment to introduce yourselves. #cancersm
Janet Freeman-Daily @JFreemanDaily
RT @MyelomaTeacher: #Myeloma peeps join in tonight's #cancersm chat #MMSM https://t.co/sJiZO9lR1s
#LCSM Chat @lcsmchat
RT @JFreemanDaily: Hi everyone! Welcome to the pancancer #CANCERSM chat on "Basics of Biomarkers Testing"! Remember to us #cancersm instea…
National Cancer Institute @theNCI
The National Cancer Institute is here. Thanks for hosting this #cancersm chat on biomarkers!
Janet Freeman-Daily @JFreemanDaily
RT @TimAllenMDJD: More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/qcE5TUfeLp
Pub Health Monitor @monitor_PH
RT @theNCI: The National Cancer Institute is here. Thanks for hosting this #cancersm chat on biomarkers! https://t.co/wizc6w6728
#LCSM Chat @lcsmchat
@subatomicdoc Greetings Matt!
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
Cindy - from NJ living with multiple myeloma #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
If you prefer just to listen, please tweet "#cancersm” so we know you’re in the audience (but I urge you ahead and join in!
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
RT @TimAllenMDJD: More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/qcE5TUfeLp
Alicia C. Staley @stales
RT @TimAllenMDJD: More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/FaMTn7FjgF
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Please do not promote products or services on the #cancersm feed or during the chat. Feel free to share vetted online resources.
#LCSM Chat @lcsmchat
RT @theNCI: The National Cancer Institute is here. Thanks for hosting this #cancersm chat on biomarkers! https://t.co/wizc6w6728
Alicia C. Staley @stales
RT @TimAllenMDJD: If you prefer just to listen, please tweet "#cancersm” so we know you’re in the audience #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
If you change someone’s words when you retweet, please label it MT (modified tweet). #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
RT @jamienholloway: Ready for tonight's chat: Basics of Biomarker Testing! #cancersm https://t.co/AoqVfpTcZw
#LCSM Chat @lcsmchat
@theNCI Welcome! Honored.
Christina Lizaso @btrfly12
Hi All - I'm passionate about community engagement and cancer. Co-founder w/ @womenofteal of #gyncsm for gynecologic cancers. Love it when the cancer communities collaborate. #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
RT @TimAllenMDJD: I’m your moderator, Tim Allen (@timallenmdjd) Pulmonary pathologist. Professor and Chair of the Department of Pathology a…
Alicia C. Staley @stales
RT @TimAllenMDJD: Please do not promote products or services on the #cancersm feed or during the chat
Alicia C. Staley @stales
@theNCI Hi there! #cancersm
Israh Akhtar Khan @israhkhan
Learn more about cancer, @ #CANCERSM
Matthew Steliga MD FACS @SteligaMD
Hello, #cancersm- following along from Little Rock.
#BTSM chat @BTSMchat
Hello #BTSM community: The #cancersm chat is happening RIGHT NOW. Use #cancersm in all of your tweets to join the discussion about the basics of biomarker testing! Do you know YOUR biomarkers?!
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Note: Twitter allows tweets up to 280 characters, but some tweetchat apps (like https://t.co/9aLQySh2dV) will not display tweets longer than 140. #cancersm
Jamie Holloway, PhD @jamienholloway
@lcsmchat Thx! Glad to join this pancancer chat! Thx for hosting! #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
Grateful for the invite to #CANCERSM (and that I finally got it on my calendar in the right place!) Excited to learn and share about biomarkers.
Liz Salmi @TheLizArmy
RT @BTSMchat: Hello #BTSM community: The #cancersm chat is happening RIGHT NOW. Use #cancersm in all of your tweets to join the discussio…
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
RT @TimAllenMDJD: Please do not promote products or services on the #cancersm feed or during the chat. Feel free to share vetted online res…
#LCSM Chat @lcsmchat
@stales @theNCI Hi Alicia!
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
RT @theNCI: The National Cancer Institute is here. Thanks for hosting this #cancersm chat on biomarkers! https://t.co/wizc6w6728
Peggy Dennis @peggyddennis
Hello! Following from Denver #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Glad to see #cancersm Twitter handles participating tonight! #GoTeam
Alicia C. Staley @stales
Hey #BCSM crew: The #cancersm chat is happening now!
Janet Freeman-Daily @JFreemanDaily
Janet Freeman-Daily in Seattle here--writer, science geek, lung cancer patient research advocate (https://t.co/OBCc87ZwkG) #CANCERSM
PF Anderson @pfanderson@disabled.social @pfanderson
RT @btrfly12: Hi All - I'm passionate about community engagement and cancer. Co-founder w/ @womenofteal of #gyncsm for gynecologic cancers.…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
I will announce FIVE topics (T1 T2 etc). Pls label your answers with T1, T2, etc to make transcript easier to follow. #cancersm
Matthew Steliga MD FACS @SteligaMD
RT @theNCI: The National Cancer Institute is here. Thanks for hosting this #cancersm chat on biomarkers! https://t.co/wizc6w6728
Alicia C. Staley @stales
I'm Alicia - Co-founder of #BCSM. 3x cancer survivor - Thanks for hosting tonight's chat! #cancersm
Bob Steele @steele_bob
Wife & I are both cancer survivors (breast, melanoma) but lung cancer advocates in honor of my dad who passed at young age of 58. #cancersm
Alicia C. Staley @stales
@lcsmchat @theNCI Hello, hello! #CancerSM
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: Glad to see #cancersm Twitter handles participating tonight! #GoTeam
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
We’ll start with Topic T1 in a minute … #cancersm
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
Hi everyone! I’m Darcy oncology nurse from Delaware looking forward to tonight’s chat! #CANCERSM
Amanda Narod @AmandaBinDC
@JFreemanDaily @gycsm Awesome! Amanda in DC. Previvor brca2+ patient advocate & cancer communications professional. Lurking and following along. #cancersm.
@jczm1991
RT @theNCI: The National Cancer Institute is here. Thanks for hosting this #cancersm chat on biomarkers! https://t.co/wizc6w6728
Liz Salmi @TheLizArmy
@TimAllenMDJD Liz here from the #BTSM/brain tumor social media community! I'm living with grade II astrocytoma and I have biomarkers! I am IDH-1 positive, ATRX negative. BOOM! Overshare. #cancersm https://t.co/aTlYGCLgKt
Israh Akhtar Khan @israhkhan
Good evening everyone, I am a Pathologist with expertise in cytopathology, breast,& pulmonary pathology #CANCERSM
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
@theNCI Glad to see you here! #MMSM #cancersm
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
Neuro-onc checking in for #btsm representation for #cancersm #biomarkers 🙌🏻
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T1: What is a biomarker and how is it identified? #cancersm
Sarika Jain @drjainsp
I am a molecular pathologist and a hematopathologist #cancersm
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
RT @TimAllenMDJD: T1: What is a biomarker and how is it identified? #cancersm
#LCSM Chat @lcsmchat
@TheLizArmy @TimAllenMDJD Hey Liz!
Christina Lizaso @btrfly12
RT @TimAllenMDJD: T1: What is a biomarker and how is it identified? #cancersm
Liz Salmi @TheLizArmy
@theNCI Nice to see @theNCI in the house! Tagging @NIHBrainTumor because they are the #BTSM homies. 😎 #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
@TimAllenMDJD Is this a quiz? Or a lecture? #CancerSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T1: There are lots of “biomarkers” of cancer, e.g., obesity is a prognostic biomarker for certain cancers. This chat focuses specifically on molecular biomarkers of cancer. Molecular biomarkers of cancer are identified by pathologists using laboratory testing. #cancersm
National Cancer Institute @theNCI
T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. https://t.co/uCNkV7yF4T #cancersm https://t.co/qxvO2FOQI0
Pub Health Monitor @monitor_PH
RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr…
Alicia C. Staley @stales
RT @TimAllenMDJD: T1: What is a biomarker and how is it identified? #cancersm #cancersm
Janet Freeman-Daily @JFreemanDaily
T1: Holding my breath waiting for all the pathologists to answer ... #CANCERSM
Hillary Andrews, PhD @HillStirSci
I’m Hillary! A frequenter of #bcsm, past breast cancer research scientist, currently working in health care policy. #cancersm
#LCSM Chat @lcsmchat
Both? #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
It's a discussion! #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
Kyle Strimbu and Jorge A. Tavel, M.D. What are Biomarkers? (2011) https://t.co/CV1ROepZnS #CancerSM
Anna Vioral (Gavin) @AnnaVioral
RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
T1- Someone tell me what a biomarker is! #MMSM #cancersm
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: It's a discussion! #cancersm https://t.co/RJQhC9XOCD
PF Anderson @pfanderson@disabled.social @pfanderson
NIEHS: Biomarkers https://t.co/cNuwLouCPJ #CancerSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: Kyle Strimbu and Jorge A. Tavel, M.D. What are Biomarkers? (2011) https://t.co/CV1ROepZnS #CancerSM
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr…
Bob Steele @steele_bob
RT @pfanderson: Kyle Strimbu and Jorge A. Tavel, M.D. What are Biomarkers? (2011) https://t.co/CV1ROepZnS #CancerSM
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: T1: There are lots of “biomarkers” of cancer, e.g., obesity is a prognostic biomarker for certain cancers. This chat foc…
Henning Willers, MD, FASTRO @HenningWillers
@theNCI T1 anything can be a biomarker. Does not have to be a molecule. #cancersm
#LCSM Chat @lcsmchat
RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: NIEHS: Biomarkers https://t.co/cNuwLouCPJ #CancerSM
PF Anderson @pfanderson@disabled.social @pfanderson
NCI Dictionary of Cancer Terms - biomarker https://t.co/rVcUwuvJ4d "A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease... Also called molecular marker and signature molecule." #CancerSM
National Cancer Institute @theNCI
T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule. #cancersm https://t.co/P7BJJJo98m
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @HenningWillers: @theNCI T1 anything can be a biomarker. Does not have to be a molecule. #cancersm
Christina Lizaso @btrfly12
RT @pfanderson: Kyle Strimbu and Jorge A. Tavel, M.D. What are Biomarkers? (2011) https://t.co/CV1ROepZnS #CancerSM
#LCSM Chat @lcsmchat
RT @pfanderson: Kyle Strimbu and Jorge A. Tavel, M.D. What are Biomarkers? (2011) https://t.co/CV1ROepZnS #CancerSM
#LCSM Chat @lcsmchat
RT @pfanderson: NIEHS: Biomarkers https://t.co/cNuwLouCPJ #CancerSM
Bob Steele @steele_bob
RT @pfanderson: NIEHS: Biomarkers https://t.co/cNuwLouCPJ #CancerSM
@TheWanForMe
RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr…
Christina Lizaso @btrfly12
RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr…
PF Anderson @pfanderson@disabled.social @pfanderson
FDA: BIOMARKER TERMINOLOGY: SPEAKING THE SAME LANGUAGE https://t.co/Ua6gPOZevl #CancerSM
#LCSM Chat @lcsmchat
RT @pfanderson: NCI Dictionary of Cancer Terms - biomarker https://t.co/rVcUwuvJ4d "A biological molecule found in blood, other body fluids…
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
RT @HenningWillers: @theNCI T1 anything can be a biomarker. Does not have to be a molecule. #cancersm
#LCSM Chat @lcsmchat
RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m…
National Cancer Institute @theNCI
T1 Tumor markers, which are a type of biomarker, have traditionally been proteins or other substances that are made by both normal and cancer cells but at higher amounts by cancer cells. https://t.co/km00Uh6EWM #cancersm
Pub Health Monitor @monitor_PH
RT @theNCI: T1 Tumor markers, which are a type of biomarker, have traditionally been proteins or other substances that are made by both nor…
PF Anderson @pfanderson@disabled.social @pfanderson
FDA: What Are Biomarkers and Why Are They Important? Transcript https://t.co/Ndpiy1XWlp #CancerSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: FDA: BIOMARKER TERMINOLOGY: SPEAKING THE SAME LANGUAGE https://t.co/Ua6gPOZevl #CancerSM
Christina Lizaso @btrfly12
RT @TimAllenMDJD: T1: There are lots of “biomarkers” of cancer, e.g., obesity is a prognostic biomarker for certain cancers. This chat foc…
#LCSM Chat @lcsmchat
RT @theNCI: T1 Tumor markers, which are a type of biomarker, have traditionally been proteins or other substances that are made by both nor…
Bob Steele @steele_bob
RT @HenningWillers: @theNCI T1 anything can be a biomarker. Does not have to be a molecule. #cancersm
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
T1- Is fever is a biomarker of infection? #cancersm
Alicia C. Staley @stales
RT @pfanderson: FDA: What Are Biomarkers and Why Are They Important? Transcript https://t.co/GmeVQy9VGa #CancerSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: FDA: What Are Biomarkers and Why Are They Important? Transcript https://t.co/Ndpiy1XWlp #CancerSM
#LCSM Chat @lcsmchat
RT @pfanderson: FDA: What Are Biomarkers and Why Are They Important? Transcript https://t.co/Ndpiy1XWlp #CancerSM
Liz Salmi @TheLizArmy
RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr…
Bob Steele @steele_bob
RT @pfanderson: FDA: BIOMARKER TERMINOLOGY: SPEAKING THE SAME LANGUAGE https://t.co/Ua6gPOZevl #CancerSM
Alicia C. Staley @stales
RT @pfanderson: FDA: BIOMARKER TERMINOLOGY: SPEAKING THE SAME LANGUAGE https://t.co/7KTEDxPF7d #CancerSM
National Cancer Institute @theNCI
T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted therapy, or whether it is responding to treatment: https://t.co/km00Uh6EWM #cancersm
Alicia C. Staley @stales
RT @pfanderson: NIEHS: Biomarkers https://t.co/xadnCHehR1 #CancerSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @MyelomaTeacher: T1- Is fever is a biomarker of infection? #cancersm
Pub Health Monitor @monitor_PH
RT @theNCI: T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted th…
#LCSM Chat @lcsmchat
RT @MyelomaTeacher: T1- Is fever is a biomarker of infection? #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @stales: RT @pfanderson: FDA: What Are Biomarkers and Why Are They Important? Transcript https://t.co/GmeVQy9VGa #CancerSM
#LCSM Chat @lcsmchat
RT @theNCI: T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted th…
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
RT @stales: RT @pfanderson: FDA: What Are Biomarkers and Why Are They Important? Transcript https://t.co/GmeVQy9VGa #CancerSM
Christina Lizaso @btrfly12
RT @theNCI: T1 Tumor markers, which are a type of biomarker, have traditionally been proteins or other substances that are made by both nor…
Alicia C. Staley @stales
@MyelomaTeacher I"m learning tonight too! #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
@lcsmchat LOL! I'm seeing great stuff being shared from a lot of different directions. Going to be a great hour! #CancerSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @stales: RT @pfanderson: NIEHS: Biomarkers https://t.co/xadnCHehR1 #CancerSM
Henning Willers, MD, FASTRO @HenningWillers
T1 A biomarker can be predictive of treatment response or prognostic for disease course independent of treatment (ok that was not really the question) #cancersm
Matthew Steliga MD FACS @SteligaMD
T1 basic info on Wikipedia: https://t.co/CfEcQ77LCv. #cancersm https://t.co/4TWuSniPGP
Bob Steele @steele_bob
RT @pfanderson: @lcsmchat LOL! I'm seeing great stuff being shared from a lot of different directions. Going to be a great hour! #CancerSM
Sarika Jain @drjainsp
T1: A Biomarker also tells you if you will respond to a treatment and also treatment response #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @stales: @MyelomaTeacher I"m learning tonight too! #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: @lcsmchat LOL! I'm seeing great stuff being shared from a lot of different directions. Going to be a great hour! #CancerSM
PF Anderson @pfanderson@disabled.social @pfanderson
RT @theNCI: T1 Tumor markers, which are a type of biomarker, have traditionally been proteins or other substances that are made by both nor…
Bob Steele @steele_bob
RT @SteligaMD: T1 basic info on Wikipedia: https://t.co/CfEcQ77LCv. #cancersm https://t.co/4TWuSniPGP
#LCSM Chat @lcsmchat
RT @pfanderson: @lcsmchat LOL! I'm seeing great stuff being shared from a lot of different directions. Going to be a great hour! #CancerSM
#LCSM Chat @lcsmchat
RT @HenningWillers: T1 A biomarker can be predictive of treatment response or prognostic for disease course independent of treatment (ok th…
#LCSM Chat @lcsmchat
RT @SteligaMD: T1 basic info on Wikipedia: https://t.co/CfEcQ77LCv. #cancersm https://t.co/4TWuSniPGP
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @SteligaMD: T1 basic info on Wikipedia: https://t.co/CfEcQ77LCv. #cancersm https://t.co/4TWuSniPGP
PF Anderson @pfanderson@disabled.social @pfanderson
RT @theNCI: T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted th…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @drjainsp: T1: A Biomarker also tells you if you will respond to a treatment and also treatment response #cancersm
Amanda Narod @AmandaBinDC
T1 lay friendly overview https://t.co/GnpK7bWJkm #cancersm @CancerDotNet
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @HenningWillers: T1 A biomarker can be predictive of treatment response or prognostic for disease course independent of treatment (ok th…
Liz Salmi @TheLizArmy
@TimAllenMDJD So I am guessing, for us brain tumor people, our biomarkers are found in the TISSUE of the tumor after it is removed or biopsied... ? #cancersm #btsm
@UppityCancerP
RT @SteligaMD: T1 basic info on Wikipedia: https://t.co/CfEcQ77LCv. #cancersm https://t.co/4TWuSniPGP
Israh Akhtar Khan @israhkhan
#CANCERSM- These are the various faces of this deadly disease a) breast cancer in bone b) hepatocellular carcinoma in ascitic fluid c) lung carcinoma invading blood vessel and Lung adenocarcinoma. What can we do to prevent it or are there any potential tests which can aid in Rx https://t.co/0C3ZOTqEO8
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AmandaBinDC: T1 lay friendly overview https://t.co/GnpK7bWJkm #cancersm @CancerDotNet
Bob Steele @steele_bob
RT @AmandaBinDC: T1 lay friendly overview https://t.co/GnpK7bWJkm #cancersm @CancerDotNet
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @TheLizArmy: @TimAllenMDJD So I am guessing, for us brain tumor people, our biomarkers are found in the TISSUE of the tumor after it is…
National Cancer Institute @theNCI
T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict the effectiveness of treatment, and to predict the chance of cancer recurrence. #CancerSM
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
#cancersm This is a great slide. #MMSM #Biomarkers https://t.co/XvmjWfL296
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @israhkhan: #CANCERSM- These are the various faces of this deadly disease a) breast cancer in bone b) hepatocellular carcinoma in asciti…
Pub Health Monitor @monitor_PH
RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T2: What is biomarker testing and what is it used for? #cancersm
Bob Steele @steele_bob
RT @israhkhan: #CANCERSM- These are the various faces of this deadly disease a) breast cancer in bone b) hepatocellular carcinoma in asciti…
Brenda Conaway @BLouConaway
RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m…
Dee Sparacio @womenofteal
Hi #CANCERSM friends, Sorry to be joining late. And trying to catch up. Dee here #gyncsm co-founder.
#LCSM Chat @lcsmchat
RT @AmandaBinDC: T1 lay friendly overview https://t.co/GnpK7bWJkm #cancersm @CancerDotNet
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict…
#LCSM Chat @lcsmchat
RT @TheLizArmy: @TimAllenMDJD So I am guessing, for us brain tumor people, our biomarkers are found in the TISSUE of the tumor after it is…
Liz Salmi @TheLizArmy
@theNCI Where's @xelamb and @GCAResearch at??? This biomarker stuff has to be your jam. #btsm #cancersm
Alicia C. Staley @stales
RT @TimAllenMDJD: T2: What is biomarker testing and what is it used for? #cancersm #cancersm
#LCSM Chat @lcsmchat
RT @israhkhan: #CANCERSM- These are the various faces of this deadly disease a) breast cancer in bone b) hepatocellular carcinoma in asciti…
#LCSM Chat @lcsmchat
RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict…
Alicia C. Staley @stales
@womenofteal hey there! #cancersm
#LCSM Chat @lcsmchat
RT @MyelomaTeacher: #cancersm This is a great slide. #MMSM #Biomarkers https://t.co/XvmjWfL296
Brenda Conaway @BLouConaway
RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr…
Matthew Steliga MD FACS @SteligaMD
RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict…
Liz Salmi @TheLizArmy
@theNCI @xelamb @GCAResearch Paging @ranjitbindra
Alicia C. Staley @stales
@TheLizArmy hey there #cancersm
Bob Steele @steele_bob
RT @MyelomaTeacher: #cancersm This is a great slide. #MMSM #Biomarkers https://t.co/XvmjWfL296
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @TheLizArmy: @theNCI Where's @xelamb and @GCAResearch at??? This biomarker stuff has to be your jam. #btsm #cancersm
National Cancer Institute @theNCI
T2 There are two main types of tumor markers that have different uses in cancer care: circulating tumor markers and tumor tissue markers. https://t.co/NfmRcRa1I1 #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @womenofteal: Hi #CANCERSM friends, Sorry to be joining late. And trying to catch up. Dee here #gyncsm co-founder.
Pub Health Monitor @monitor_PH
RT @theNCI: T2 There are two main types of tumor markers that have different uses in cancer care: circulating tumor markers and tumor tissu…
Sarika Jain @drjainsp
T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @theNCI: T2 There are two main types of tumor markers that have different uses in cancer care: circulating tumor markers and tumor tissu…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Welcome! #cancersm
Alicia C. Staley @stales
RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm
#LCSM Chat @lcsmchat
RT @theNCI: T2 There are two main types of tumor markers that have different uses in cancer care: circulating tumor markers and tumor tissu…
Bob Steele @steele_bob
RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm
National Cancer Institute @theNCI
T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cancer, are used, for example, to estimate prognosis and to assess the response to treatment. #CancerSM
#LCSM Chat @lcsmchat
RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm
Dee Sparacio @womenofteal
RT @stales: RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #can
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T2: Molecular biomarker testing involves laboratory tests that evaluate and identify the presence, on the surface of a cancer cell for e.g. a protein, or the identification of mutations or other changes in the cancer cell genes. #cancersm
#LCSM Chat @lcsmchat
RT @theNCI: T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cance…
Pub Health Monitor @monitor_PH
RT @theNCI: T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cance…
Liz Salmi @TheLizArmy
@HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No longer do we talk about the types or grades (i.e. stage) of our tumors, we talk about our biomarkers. For reals. 🤓 #BTSM #cancersm
@UppityCancerP
RT @pfanderson: NIEHS: Biomarkers https://t.co/cNuwLouCPJ #CancerSM
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm
National Cancer Institute @theNCI
T2 Tumor tissue markers, which are found in actual tumors, are used to diagnose, stage, and/or classify cancer, to estimate prognosis, and to select an appropriate treatment (e.g., treatment with a targeted therapy). #cancersm
Christina Lizaso @btrfly12
RT @HenningWillers: T1 A biomarker can be predictive of treatment response or prognostic for disease course independent of treatment (ok th…
Jamie Holloway, PhD @jamienholloway
T2: In cancer, biomarker testing is analysis of DNA, RNA, or proteins that provide info about the diagnosis, prognosis, or are predictive for response to treatment #CANCERSM
@UppityCancerP
RT @theNCI: T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cance…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @TheLizArmy: @HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No lon…
Christina Lizaso @btrfly12
RT @SteligaMD: T1 basic info on Wikipedia: https://t.co/CfEcQ77LCv. #cancersm https://t.co/4TWuSniPGP
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: T2: Molecular biomarker testing involves laboratory tests that evaluate and identify the presence, on the surface of a c…
Jamie Holloway, PhD @jamienholloway
@TheLizArmy @HenningWillers We do that in the breast cancer world, too! #cancersm
#LCSM Chat @lcsmchat
RT @TheLizArmy: @HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No lon…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
This #cancersm
#LCSM Chat @lcsmchat
RT @jamienholloway: T2: In cancer, biomarker testing is analysis of DNA, RNA, or proteins that provide info about the diagnosis, prognosis,…
National Cancer Institute @theNCI
T2 If you are interested in learning more about tumor markers, please see our expert-reviewed fact sheet on these biomarkers: https://t.co/km00Uh6EWM #cancersm
Ginger Riley ~Eternal Optimist~ @gingerly21
RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr…
Henning Willers, MD, FASTRO @HenningWillers
@stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm
#LCSM Chat @lcsmchat
RT @theNCI: T2 If you are interested in learning more about tumor markers, please see our expert-reviewed fact sheet on these biomarkers: h…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @jamienholloway: @TheLizArmy @HenningWillers We do that in the breast cancer world, too! #cancersm
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @jamienholloway: T2: In cancer, biomarker testing is analysis of DNA, RNA, or proteins that provide info about the diagnosis, prognosis,…
Alicia C. Staley @stales
RT @HenningWillers: @stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm
#LCSM Chat @lcsmchat
RT @HenningWillers: @stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm
Bob Steele @steele_bob
RT @HenningWillers: @stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @HenningWillers: @stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm
Sarika Jain @drjainsp
T2 An example of a diagnostic biomarker is prostate-specific antigen (PSA) used for screening of prostate cancer. An example of a therapeutic biomarker is EGFR gene testing in patients with lung cancer.#cancersm
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
RT @HenningWillers: @stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm
🌎 Sal @J1262Sal
RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict…
PF Anderson @pfanderson@disabled.social @pfanderson
@theNCI It has been an amazing ride the past couple decades, watching noninvasive biomarker testing emerge & become refined. First predicted in the early 1900s, and they made fun of the guy then. Now we have salivary & urinary & breath analysis #CancerSM
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@TheLizArmy @HenningWillers T1: And it changed in 2016 as the WHO reclassified gliomas #btsm #cancersm https://t.co/gcDDoZ7Rqb
PF Anderson @pfanderson@disabled.social @pfanderson
RT @TimAllenMDJD: T2: What is biomarker testing and what is it used for? #cancersm
Liz Salmi @TheLizArmy
@TimAllenMDJD T2: For the brain community, our tumors are tested for biomarkers as a way of determining whether our tumor is more or less aggressive and likely to respond more favorably to various treatments. Treatment decisions are based on biomarkers. #btsm #cancersm
Sarah Temkin @temkins
RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AshleySumrallMD: @TheLizArmy @HenningWillers T1: And it changed in 2016 as the WHO reclassified gliomas #btsm #cancersm https://t.co/gc…
Christina Lizaso @btrfly12
RT @TheLizArmy: @HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No lon…
Janet Freeman-Daily @JFreemanDaily
@theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural fluid often also contains tumor cells that can undergo biomarker testing. #LCSM #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
RT @theNCI: T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cance…
#LCSM Chat @lcsmchat
RT @AshleySumrallMD: @TheLizArmy @HenningWillers T1: And it changed in 2016 as the WHO reclassified gliomas #btsm #cancersm https://t.co/gc…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @TimAllenMDJD: T2: Molecular biomarker testing involves laboratory tests that evaluate and identify the presence, on the surface of a c…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
@theNCI Would the measurement of my m-protien in my blood be considered a biomarker for myeloma ? #MMSM #CancerSM
Israh Akhtar Khan @israhkhan
#CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need hormonal therapy or chemotherapy or Herceptin, more recently in April 2019, immunotherapy has been approved by FDA in triple negative breast ca patients https://t.co/qurV1a4y3i
#LCSM Chat @lcsmchat
RT @TheLizArmy: @TimAllenMDJD T2: For the brain community, our tumors are tested for biomarkers as a way of determining whether our tumor i…
Henning Willers, MD, FASTRO @HenningWillers
@drjainsp T2 interestingly PSA can also be predictive of treatment outcome and also prognostic #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
RT @AshleySumrallMD: @TheLizArmy @HenningWillers T1: And it changed in 2016 as the WHO reclassified gliomas #btsm #cancersm https://t.co/gc…
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural flui…
Bob Steele @steele_bob
RT @AshleySumrallMD: @TheLizArmy @HenningWillers T1: And it changed in 2016 as the WHO reclassified gliomas #btsm #cancersm https://t.co/gc…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Already needs to be updated. Our understanding of cancer biomarkers is evolving fast! #cancersm
#LCSM Chat @lcsmchat
RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h…
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @JFreemanDaily: @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural flui…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @HenningWillers: @drjainsp T2 interestingly PSA can also be predictive of treatment outcome and also prognostic #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @MyelomaTeacher: @theNCI Would the measurement of my m-protien in my blood be considered a biomarker for myeloma ? #MMSM #CancerSM
#LCSM Chat @lcsmchat
RT @HenningWillers: @drjainsp T2 interestingly PSA can also be predictive of treatment outcome and also prognostic #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @JFreemanDaily: @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural flui…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @TheLizArmy: @TimAllenMDJD T2: For the brain community, our tumors are tested for biomarkers as a way of determining whether our tumor i…
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: Already needs to be updated. Our understanding of cancer biomarkers is evolving fast! #cancersm https://t.co/MXre3PKV9L
PF Anderson @pfanderson@disabled.social @pfanderson
Salivary Biomarkers: Toward Future Clinical and Diagnostic Utilities https://t.co/Q4bzv0UQoc Salivary biomarkers and proteomics: future diagnostic and clinical utilities https://t.co/Epp0cUOsdq #CancerSM
PF Anderson @pfanderson@disabled.social @pfanderson
RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h…
Bob Steele @steele_bob
RT @HenningWillers: @drjainsp T2 interestingly PSA can also be predictive of treatment outcome and also prognostic #cancersm
Sarika Jain @drjainsp
RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h…
♛ ℯƖ ღ @EL504_
RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict…
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
RT @JFreemanDaily: @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural flui…
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@TimAllenMDJD True! Esp for #H3K27m mutants
Dennis Keim @denniskeim
RT @pfanderson: Kyle Strimbu and Jorge A. Tavel, M.D. What are Biomarkers? (2011) https://t.co/CV1ROepZnS #CancerSM
Janet Freeman-Daily @JFreemanDaily
Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM #cancersm
National Cancer Institute @theNCI
RT @JFreemanDaily: @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural flui…
Jose Hernandez @Pharma_Mty
RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict…
National Cancer Institute @theNCI
RT @TheLizArmy: @TimAllenMDJD T2: For the brain community, our tumors are tested for biomarkers as a way of determining whether our tumor i…
#LCSM Chat @lcsmchat
RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM
Liz Salmi @TheLizArmy
@TimAllenMDJD In 2016 [REDACTED USER] released a NEW classification of CNS tumors (central nervous system) related to "new" knowledge about biomarkers. This new classification system kind of rocked the brain tumor world and it was really exciting for the #neuropath community. #btsm #cancersm
National Cancer Institute @theNCI
RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM
Deb 🌅 @debsmithbeach
Deb from NH here, sorry to be late. #cancersm
#LCSM Chat @lcsmchat
RT @TheLizArmy: @TimAllenMDJD In 2016 [REDACTED USER] released a NEW classification of CNS tumors (central nervous system) related to "new" knowledge…
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@TheLizArmy @TimAllenMDJD Except there are places that STILL don’t routinely check #MGMT & #IDH in glioma #btsm #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @TheLizArmy: @TimAllenMDJD In 2016 [REDACTED USER] released a NEW classification of CNS tumors (central nervous system) related to "new" knowledge…
Dee Sparacio @womenofteal
@drjainsp And CA-125 is used as a biomarker to measure response to treatment for many women with #ovca #gyncsm #CANCERSM
PF Anderson @pfanderson@disabled.social @pfanderson
@JFreemanDaily @theNCI Even breath! >> VOC breath biomarkers in lung cancer (2016) https://t.co/TmvUTPyxkp Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening (2015) https://t.co/ccpsi93wS2 #CancerSM
Dee Sparacio @womenofteal
RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h…
Vinny502 @VMendez502
RT @jamienholloway: T2: In cancer, biomarker testing is analysis of DNA, RNA, or proteins that provide info about the diagnosis, prognosis,…
Liz Salmi @TheLizArmy
@AshleySumrallMD @HenningWillers Yes! I just tweeted that! LOL Use #cancersm for tonight's chat. ;)
Dennis Keim @denniskeim
RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Welcome! #cancersm
#LCSM Chat @lcsmchat
RT @AshleySumrallMD: @TheLizArmy @TimAllenMDJD Except there are places that STILL don’t routinely check #MGMT & #IDH in glioma #btsm #cance
#LCSM Chat @lcsmchat
RT @womenofteal: @drjainsp And CA-125 is used as a biomarker to measure response to treatment for many women with #ovca #gyncsm #CANCERSM
PF Anderson @pfanderson@disabled.social @pfanderson
RT @TheLizArmy: @HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No lon…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @womenofteal: @drjainsp And CA-125 is used as a biomarker to measure response to treatment for many women with #ovca #gyncsm #CANCERSM
#LCSM Chat @lcsmchat
RT @pfanderson: @JFreemanDaily @theNCI Even breath! >> VOC breath biomarkers in lung cancer (2016) https://t.co/TmvUTPyxkp Blinded Validat…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AshleySumrallMD: @TheLizArmy @TimAllenMDJD Except there are places that STILL don’t routinely check #MGMT & #IDH in glioma #btsm #cance
Sarika Jain @drjainsp
@MyelomaTeacher @theNCI Yes! the level of M-Protein is important to know disease progression.
Bob Steele @steele_bob
RT @AshleySumrallMD: @TheLizArmy @TimAllenMDJD Except there are places that STILL don’t routinely check #MGMT & #IDH in glioma #btsm #cance
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @TheLizArmy: @AshleySumrallMD @HenningWillers Yes! I just tweeted that! LOL Use #cancersm for tonight's chat. ;)
Andrea @BraveBosom
RT @TheLizArmy: @HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No lon…
Liz Salmi @TheLizArmy
RT @AshleySumrallMD: @TheLizArmy @HenningWillers T1: And it changed in 2016 as the WHO reclassified gliomas #btsm #cancersm https://t.co/gc…
Dennis Keim @denniskeim
RT @HenningWillers: @stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether or not a patient might respond to a molecular therapy; and prognostic biomarkers help determine the patient’s chances for long-term survival. #cancersm
Christina Lizaso @btrfly12
T2: Here's an overview of what is being studied for #ovariancancer Diagnostic and Prognostic Biomarkers in ovarian cancer and the potential roles of cancer stem cells – An updated review https://t.co/Lo7npjtVOw #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @btrfly12: T2: Here's an overview of what is being studied for #ovariancancer Diagnostic and Prognostic Biomarkers in ovarian cancer an…
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@TheLizArmy @TimAllenMDJD Yes. Some experimental csf tests, but still not the norm
Andrea @BraveBosom
RT @btrfly12: T2: Here's an overview of what is being studied for #ovariancancer Diagnostic and Prognostic Biomarkers in ovarian cancer an…
National Cancer Institute @theNCI
RT @TimAllenMDJD: T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether…
Christina Lizaso @btrfly12
RT @TheLizArmy: @TimAllenMDJD In 2016 [REDACTED USER] released a NEW classification of CNS tumors (central nervous system) related to "new" knowledge…
PF Anderson @pfanderson@disabled.social @pfanderson
@TheLizArmy @HenningWillers That's amazing. Many folk I know with childhood trauma introduce themselves with their ACE score, but psych professionals I know have trouble believing this happens. I bet the docs are surprised. #CancerSM
Christina Lizaso @btrfly12
RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM
Dennis Keim @denniskeim
RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h…
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @TimAllenMDJD: T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether…
Dennis Keim @denniskeim
RT @HenningWillers: @drjainsp T2 interestingly PSA can also be predictive of treatment outcome and also prognostic #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T3: What treatment options can be identified through biomarker testing? #cancersm
Dennis Keim @denniskeim
RT @TimAllenMDJD: Already needs to be updated. Our understanding of cancer biomarkers is evolving fast! #cancersm https://t.co/MXre3PKV9L
Dee Sparacio @womenofteal
#gyncsm
Liz Salmi @TheLizArmy
Great point! People facing a brain tumor--if diagnosed at a community hospital--might not be told about biomarker testing... which is absolutely CRUCIAL to our treatment. #BTSM #cancersm
#LCSM Chat @lcsmchat
RT @pfanderson: @TheLizArmy @HenningWillers That's amazing. Many folk I know with childhood trauma introduce themselves with their ACE scor…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @btrfly12: T2: Here's an overview of what is being studied for #ovariancancer Diagnostic and Prognostic Biomarkers in ovarian cancer an…
Dee Sparacio @womenofteal
RT @TimAllenMDJD: T3: What treatment options can be identified through biomarker testing? #cancersm
Liz Salmi @TheLizArmy
RT @TimAllenMDJD: Already needs to be updated. Our understanding of cancer biomarkers is evolving fast! #cancersm https://t.co/MXre3PKV9L
@UppityCancerP
RT @pfanderson: Salivary Biomarkers: Toward Future Clinical and Diagnostic Utilities https://t.co/Q4bzv0UQoc Salivary biomarkers and proteo…
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: T3: What treatment options can be identified through biomarker testing? #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @TheLizArmy: Great point! People facing a brain tumor--if diagnosed at a community hospital--might not be told about biomarker testing..…
National Cancer Institute @theNCI
T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in common use: https://t.co/NtPLX1lStR #cancersm
Henning Willers, MD, FASTRO @HenningWillers
RT @TimAllenMDJD: T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether…
#LCSM Chat @lcsmchat
RT @TheLizArmy: Great point! People facing a brain tumor--if diagnosed at a community hospital--might not be told about biomarker testing..…
Pub Health Monitor @monitor_PH
RT @theNCI: T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in commo…
@UppityCancerP
RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h…
Christina Lizaso @btrfly12
RT @TheLizArmy: Great point! People facing a brain tumor--if diagnosed at a community hospital--might not be told about biomarker testing..…
Andrea @BraveBosom
Hi! Taking a break from vacation to say hello TY for organizing this combined chat. I am here from #BRCA community 👏 #cancersm.
Dennis Keim @denniskeim
RT @womenofteal: @drjainsp And CA-125 is used as a biomarker to measure response to treatment for many women with #ovca #gyncsm #CANCERSM
Janet Freeman-Daily @JFreemanDaily
RT @pfanderson: @JFreemanDaily @theNCI Even breath! >> VOC breath biomarkers in lung cancer (2016) https://t.co/TmvUTPyxkp Blinded Validat…
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@TimAllenMDJD T3 In #glioma, we use biomarkers as part of trial eligibilty. For ex: #MGMT status (although it is controversial) #btsm #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
RT @TimAllenMDJD: T3: What treatment options can be identified through biomarker testing? #cancersm
National Cancer Institute @theNCI
T3 In breast cancer, testing tumors for estrogen and progesterone receptors and the HER2 protein can help doctors help determine whether treatment with hormone therapy or some targeted therapies is appropriate. #CancerSM
PF Anderson @pfanderson@disabled.social @pfanderson
RT @theNCI: T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in commo…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AshleySumrallMD: @TimAllenMDJD T3 In #glioma, we use biomarkers as part of trial eligibilty. For ex: #MGMT status (although it is contr…
Liz Salmi @TheLizArmy
RT @AshleySumrallMD: @TimAllenMDJD T3 In #glioma, we use biomarkers as part of trial eligibilty. For ex: #MGMT status (although it is contr…
@spartychemist
Biomarkers are indicators that are used to predict or diagnose condition.. in blood cancer patients .presence of certain dna or rna in blood
National Cancer Institute @theNCI
T3 In non-small cell lung cancer, an analysis of mutations in the EGFR gene can help doctors determine a patient’s treatment and estimate prognosis. #cancersm #lcsm
Pub Health Monitor @monitor_PH
RT @theNCI: T3 In non-small cell lung cancer, an analysis of mutations in the EGFR gene can help doctors determine a patient’s treatment an…
PF Anderson @pfanderson@disabled.social @pfanderson
@TimAllenMDJD I'm curious about the balance between biomarkers and genome for informing treatment decisions and planning #CancerSM
#LCSM Chat @lcsmchat
RT @AshleySumrallMD: @TimAllenMDJD T3 In #glioma, we use biomarkers as part of trial eligibilty. For ex: #MGMT status (although it is contr…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
@TimAllenMDJD Can prognostic biomarkers be a group of biomarkers that stratify for risk instead of just 1 biomarker? #MMSM #CancerSM
#LCSM Chat @lcsmchat
RT @theNCI: T3 In breast cancer, testing tumors for estrogen and progesterone receptors and the HER2 protein can help doctors help determin…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @TimAllenMDJD: T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether…
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@TimAllenMDJD T3: identifying #NTRK fusion in #glioma (est 1% of gliomas) opens up avenues for 2 therapies #btsm #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: @TimAllenMDJD I'm curious about the balance between biomarkers and genome for informing treatment decisions and planning #C
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @MyelomaTeacher: @TimAllenMDJD Can prognostic biomarkers be a group of biomarkers that stratify for risk instead of just 1 biomarker? #M
Bob Steele @steele_bob
Glad to report Wife has final infusion sched 7/22. But dx'd Mon with new side effect: cornea thinning. Hadn't heard of that one. #cancersm
Henning Willers, MD, FASTRO @HenningWillers
T3 in lung cancer oncogenic alterations in EGFR ALK ROS1 RET et cetera determine treatment choicces #lcsm #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
RT @theNCI: T3 In breast cancer, testing tumors for estrogen and progesterone receptors and the HER2 protein can help doctors help determin…
Dee Sparacio @womenofteal
@pfanderson @TimAllenMDJD great question. #cancersm
c0nc0rdance @c0nc0rdance
#CancerSM is a Twitter chat discussing the basics of biomarker testing for cancer. If it's a topic you're interested in, the participants are doing a great job of making cancer diagnostics accessible to anyone. Love that scientists/clinicians do this kind of outreach.
Dennis Keim @denniskeim
Greetings. Checking in bit late too but catching up. Another #bcsm peep. Interesting chat tonight. #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AshleySumrallMD: @TimAllenMDJD T3: identifying #NTRK fusion in #glioma (est 1% of gliomas) opens up avenues for 2 therapies #btsm #canc
National Cancer Institute @theNCI
T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #immunotherapy drug called an immune checkpoint inhibitor is appropriate. #cancersm https://t.co/n66X2nteXz
#LCSM Chat @lcsmchat
RT @pfanderson: @TimAllenMDJD I'm curious about the balance between biomarkers and genome for informing treatment decisions and planning #C
#LCSM Chat @lcsmchat
RT @MyelomaTeacher: @TimAllenMDJD Can prognostic biomarkers be a group of biomarkers that stratify for risk instead of just 1 biomarker? #M
Pub Health Monitor @monitor_PH
RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im
#LCSM Chat @lcsmchat
RT @AshleySumrallMD: @TimAllenMDJD T3: identifying #NTRK fusion in #glioma (est 1% of gliomas) opens up avenues for 2 therapies #btsm #canc
Laronica Conway @louisianagirl91
Great collaboration!!! 👍🏾 #LCSM #CANCERSM
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
RT @AshleySumrallMD: @TimAllenMDJD T3 In #glioma, we use biomarkers as part of trial eligibilty. For ex: #MGMT status (although it is contr…
Israh Akhtar Khan @israhkhan
#cancersm Other well known diagnostic biomarkers are AFP for hepatocellular carcinoma, CA19-9 for pancreatic Ca, CEA for colo-rectal Ca, HCG for choriocarcinoma
Henning Willers, MD, FASTRO @HenningWillers
T3 often overlooked, in #radonc tumor size/volume determines radiation dose and whether chemotherapy should be added #cancersm
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@TimAllenMDJD T3: and... finding #H3K27m mutations opens the door to try drugs like #ONC201 (as seen at #ASCO19) #cancersm
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
@spartychemist Thanks. So my m-spike is a biomarker of my cancer. #MMSM #cancerSM
Bob Steele @steele_bob
RT @louisianagirl91: Great collaboration!!! 👍🏾 #LCSM #CANCERSM https://t.co/WYiLZac5bP
#LCSM Chat @lcsmchat
RT @c0nc0rdance: #CancerSM is a Twitter chat discussing the basics of biomarker testing for cancer. If it's a topic you're interested in,…
Henning Willers, MD, FASTRO @HenningWillers
RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im
Liz Salmi @TheLizArmy
@AshleySumrallMD @TimAllenMDJD I was diagnosed with a brain tumor in 2008 when checking for biomarkers was not part of standard of care. In 2016, I asked my neuro-onc to run my tissue for the biomarkers panel. He asked, "Why would you want to know what your biomarkers are?" #btsm #cancersm https://t.co/BGY4SHbgDn
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
My best to your wife. #cancersm
Dee Sparacio @womenofteal
#gyncsm
Jamie Holloway, PhD @jamienholloway
T3: SO MANY OPTIONS can be identified through biomarkers. Hormone therapy, immunotherapy, targeted kinase inhibitors, antibodies like herceptin... They can also point to clinical trials #cancersm
c0nc0rdance @c0nc0rdance
@TimAllenMDJD This is great stuff. Thank you so much to all the participants! Really enjoying the discussion.
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @MyelomaTeacher: @spartychemist Thanks. So my m-spike is a biomarker of my cancer. #MMSM #cancerSM
PF Anderson @pfanderson@disabled.social @pfanderson
@womenofteal @TimAllenMDJD We hear a lot these days about analyzing tumor genomes for resistant cases, and we hear about the rare miracles, but ... there are a lot of non-miracles, and it's still really new. #CancerSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @HenningWillers: T3 often overlooked, in #radonc tumor size/volume determines radiation dose and whether chemotherapy should be added #c
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @israhkhan: #cancersm Other well known diagnostic biomarkers are AFP for hepatocellular carcinoma, CA19-9 for pancreatic Ca, CEA for col…
Janet Freeman-Daily @JFreemanDaily
@theNCI Analysis of mutations in EGFR+ NSCLC (and other oncogene-driven cancers) can also help determine how to treat resistance to targeted therapies. #LCSM #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @louisianagirl91: Great collaboration!!! 👍🏾 #LCSM #CANCERSM https://t.co/WYiLZac5bP
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im
Andrea @BraveBosom
@womenofteal @drjainsp CA125 has a ton of false positives/ can be inaccurate. I have had quite a few scares. Hope for better biomarkers in the future for #brca. #cancersm
Laronica Conway @louisianagirl91
👋🏾👋🏾 Hey Dr. Tim! Late and lurking! 👀 🤗 #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @denniskeim: Greetings. Checking in bit late too but catching up. Another #bcsm peep. Interesting chat tonight. #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @c0nc0rdance: #CancerSM is a Twitter chat discussing the basics of biomarker testing for cancer. If it's a topic you're interested in,…
#LCSM Chat @lcsmchat
RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im
PF Anderson @pfanderson@disabled.social @pfanderson
RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im
Dee Sparacio @womenofteal
RT @israhkhan: #cancersm Other well known diagnostic biomarkers are AFP for hepatocellular carcinoma, CA19-9 for pancreatic Ca, CEA for col…
Liz Salmi @TheLizArmy
RT @c0nc0rdance: #CancerSM is a Twitter chat discussing the basics of biomarker testing for cancer. If it's a topic you're interested in,…
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @israhkhan: #cancersm Other well known diagnostic biomarkers are AFP for hepatocellular carcinoma, CA19-9 for pancreatic Ca, CEA for col…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @c0nc0rdance: #CancerSM is a Twitter chat discussing the basics of biomarker testing for cancer. If it's a topic you're interested in,…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: @womenofteal @TimAllenMDJD We hear a lot these days about analyzing tumor genomes for resistant cases, and we hear about th…
#LCSM Chat @lcsmchat
RT @israhkhan: #cancersm Other well known diagnostic biomarkers are AFP for hepatocellular carcinoma, CA19-9 for pancreatic Ca, CEA for col…
c0nc0rdance @c0nc0rdance
RT @theNCI: T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted th…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T3: Therapeutic molecular biomarker tests identify a therapeutic target for which there is a currently available drug. #cancersm
#LCSM Chat @lcsmchat
RT @HenningWillers: T3 often overlooked, in #radonc tumor size/volume determines radiation dose and whether chemotherapy should be added #c
#LCSM Chat @lcsmchat
RT @AshleySumrallMD: @TimAllenMDJD T3: and... finding #H3K27m mutations opens the door to try drugs like #ONC201 (as seen at #ASCO19) #canc
Henning Willers, MD, FASTRO @HenningWillers
RT @JFreemanDaily: @theNCI Analysis of mutations in EGFR+ NSCLC (and other oncogene-driven cancers) can also help determine how to treat re…
#LCSM Chat @lcsmchat
RT @MyelomaTeacher: @spartychemist Thanks. So my m-spike is a biomarker of my cancer. #MMSM #cancerSM
#LCSM Chat @lcsmchat
RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD I was diagnosed with a brain tumor in 2008 when checking for biomarkers was not part of stan…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD I was diagnosed with a brain tumor in 2008 when checking for biomarkers was not part of stan…
#LCSM Chat @lcsmchat
RT @jamienholloway: T3: SO MANY OPTIONS can be identified through biomarkers. Hormone therapy, immunotherapy, targeted kinase inhibitors, a…
#LCSM Chat @lcsmchat
RT @pfanderson: @womenofteal @TimAllenMDJD We hear a lot these days about analyzing tumor genomes for resistant cases, and we hear about th…
Christina Lizaso @btrfly12
@steele_bob We were just hearing about eye-related side effects on last night's #gyncsm chat about maintenance therapies. #cancersm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @theNCI Analysis of mutations in EGFR+ NSCLC (and other oncogene-driven cancers) can also help determine how to treat re…
#LCSM Chat @lcsmchat
RT @BraveBosom: @womenofteal @drjainsp CA125 has a ton of false positives/ can be inaccurate. I have had quite a few scares. Hope for bet…
Israh Akhtar Khan @israhkhan
#CANCERSM advanced lung cancer patients may be responsive to immunotherapy (keytruda)if the tumor cells are PDL1 positive
c0nc0rdance @c0nc0rdance
RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m…
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: T3: Therapeutic molecular biomarker tests identify a therapeutic target for which there is a currently available drug. #…
Christina Lizaso @btrfly12
RT @c0nc0rdance: #CancerSM is a Twitter chat discussing the basics of biomarker testing for cancer. If it's a topic you're interested in,…
#LCSM Chat @lcsmchat
RT @btrfly12: @steele_bob We were just hearing about eye-related side effects on last night's #gyncsm chat about maintenance therapies. #ca
eduardo cervera @emircervera
RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
@theNCI In myeloma the expression of BCMA is used as a biomarker for CAR-T cell therapy #MMSM #cancerSM
#LCSM Chat @lcsmchat
RT @israhkhan: #CANCERSM advanced lung cancer patients may be responsive to immunotherapy (keytruda)if the tumor cells are PDL1 positive
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Howdy, @louisianagirl91! Glad you're here at #cancersm
National Cancer Institute @theNCI
RT @TimAllenMDJD: T3: Therapeutic molecular biomarker tests identify a therapeutic target for which there is a currently available drug. #…
c0nc0rdance @c0nc0rdance
RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im
Dennis Keim @denniskeim
RT @israhkhan: #CANCERSM advanced lung cancer patients may be responsive to immunotherapy (keytruda)if the tumor cells are PDL1 positive
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @israhkhan: #CANCERSM advanced lung cancer patients may be responsive to immunotherapy (keytruda)if the tumor cells are PDL1 positive
Dennis Keim @denniskeim
RT @MyelomaTeacher: @theNCI In myeloma the expression of BCMA is used as a biomarker for CAR-T cell therapy #MMSM #cancerSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @MyelomaTeacher: @theNCI In myeloma the expression of BCMA is used as a biomarker for CAR-T cell therapy #MMSM #cancerSM
Henning Willers, MD, FASTRO @HenningWillers
T3 are there any biomarkers that determine choice of surgery, for or against ? #cancersm
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as we keep testing & building data. #btsm #hncsm #thycsm #cancersm https://t.co/KV6Ct0nXaS
Frufruit @_lulyf
RT @TimAllenMDJD: T3: Therapeutic molecular biomarker tests identify a therapeutic target for which there is a currently available drug. #…
Liz Salmi @TheLizArmy
@TimAllenMDJD Would it be fair to say "biomarkers are the new pathology?" Or is it a teamwork between the two? #btsm #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
@BraveBosom @womenofteal @drjainsp Agree! That's one of the messy ones (CA125), and that it is so inconsistent directly connects with lack of testing and unwillingness to pursue costly invasive explorations for #OvCa and some other #GynCSM #CancerSM
Dee Sparacio @womenofteal
@BraveBosom @drjainsp Yes we need a better biomarker or set of biomarkers to screen for OC. It is not a good marker for me either . #gyncsm #cancersm
#LCSM Chat @lcsmchat
RT @HenningWillers: T3 are there any biomarkers that determine choice of surgery, for or against ? #cancersm
Jamie Holloway, PhD @jamienholloway
RT @AshleySumrallMD: @TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as w…
#LCSM Chat @lcsmchat
RT @AshleySumrallMD: @TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as w…
Christina Lizaso @btrfly12
RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD I was diagnosed with a brain tumor in 2008 when checking for biomarkers was not part of stan…
#LCSM Chat @lcsmchat
RT @TheLizArmy: @TimAllenMDJD Would it be fair to say "biomarkers are the new pathology?" Or is it a teamwork between the two? #btsm #can
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@TheLizArmy @TimAllenMDJD Oh @TheLizArmy ☹️
Liz Salmi @TheLizArmy
@btrfly12 @steele_bob EYE-RELATED SIDE EFFECTS? Wow. #cancersm
Janet Freeman-Daily @JFreemanDaily
Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tested for EGFR (despite having FDA-approved treatments). % for other NSCLC genomic drivers is even less. Frustrating! #LCSM #cancersm
Christina Lizaso @btrfly12
RT @jamienholloway: T3: SO MANY OPTIONS can be identified through biomarkers. Hormone therapy, immunotherapy, targeted kinase inhibitors, a…
Bob Steele @steele_bob
RT @TheLizArmy: @TimAllenMDJD Would it be fair to say "biomarkers are the new pathology?" Or is it a teamwork between the two? #btsm #can
Andrea @BraveBosom
RT @womenofteal: @BraveBosom @drjainsp Yes we need a better biomarker or set of biomarkers to screen for OC. It is not a good marker for m…
Sarika Jain @drjainsp
RT @israhkhan: #CANCERSM advanced lung cancer patients may be responsive to immunotherapy (keytruda)if the tumor cells are PDL1 positive
PF Anderson @pfanderson@disabled.social @pfanderson
RT @AshleySumrallMD: @TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as w…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
@TimAllenMDJD Is there a listing of approved FDA oncology drugs with their tested and verified biomarker? #MMSM
Christina Lizaso @btrfly12
RT @BraveBosom: @womenofteal @drjainsp CA125 has a ton of false positives/ can be inaccurate. I have had quite a few scares. Hope for bet…
Sabin Motwani @sabinbmotwanimd
Also important not only to find therapeutic biomarkers but also markers of resistance #cancersm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tes…
Dee Sparacio @womenofteal
RT @TheLizArmy: @TimAllenMDJD Would it be fair to say "biomarkers are the new pathology?" Or is it a teamwork between the two? #btsm #can
yetAnotherName @glostaMAssachu
RT @pfanderson: @womenofteal @TimAllenMDJD We hear a lot these days about analyzing tumor genomes for resistant cases, and we hear about th…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Fair enough! #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AshleySumrallMD: @TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as w…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @HenningWillers: T3 are there any biomarkers that determine choice of surgery, for or against ? #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @sabinbmotwanimd: Also important not only to find therapeutic biomarkers but also markers of resistance #cancersm
#LCSM Chat @lcsmchat
RT @sabinbmotwanimd: Also important not only to find therapeutic biomarkers but also markers of resistance #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @JFreemanDaily: Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tes…
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
@HenningWillers Do chromogranin/synaptophysin count to help in lung cancer? #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @TheLizArmy: @btrfly12 @steele_bob EYE-RELATED SIDE EFFECTS? Wow. #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T3: If the molecular biomarker testing shows that the patient's cancer contains the therapeutic target, then that patient might benefit from treatment with the corresponding drug. This is personalized medicine! #cancersm
Jamie Holloway, PhD @jamienholloway
Excellent point! It's just as important to know what drugs *won't* work! #cancersm
Henning Willers, MD, FASTRO @HenningWillers
RT @JFreemanDaily: Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tes…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
RT @JFreemanDaily: Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tes…
#LCSM Chat @lcsmchat
RT @subatomicdoc: @HenningWillers Do chromogranin/synaptophysin count to help in lung cancer? #cancersm
Christina Lizaso @btrfly12
RT @AshleySumrallMD: @TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as w…
yetAnotherName @glostaMAssachu
@pfanderson @womenofteal @TimAllenMDJD Yes, but we will persist!
🅰🅼🆈🅷🅳🅴🅴🅺🅴🅽🅼🅳 @AmyHDeekenMD
RT @TimAllenMDJD: T3: Therapeutic molecular biomarker tests identify a therapeutic target for which there is a currently available drug. #…
Liz Salmi @TheLizArmy
RT @JFreemanDaily: Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tes…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @jamienholloway: Excellent point! It's just as important to know what drugs *won't* work! #cancersm https://t.co/ozpQTMRriS
#LCSM Chat @lcsmchat
RT @jamienholloway: Excellent point! It's just as important to know what drugs *won't* work! #cancersm https://t.co/ozpQTMRriS
National Cancer Institute @theNCI
RT @jamienholloway: Excellent point! It's just as important to know what drugs *won't* work! #cancersm https://t.co/ozpQTMRriS
Sarika Jain @drjainsp
T3: On the other hand, if a patient's biomarker testing does not show that that patient's cancer contains that therapeutic target on the cancer cell, then treating that patient with the corresponding, often expensive drug would provide no therapeutic benefit. #cancersm
Dee Sparacio @womenofteal
RT @TimAllenMDJD: T3: If the molecular biomarker testing shows that the patient's cancer contains the therapeutic target, then that patien…
Henning Willers, MD, FASTRO @HenningWillers
@JFreemanDaily @NCCN T3 moreover #lungcancer patients with non-metastatic disease are even less often tested for these mutations #cancersm #lcsm
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
RT @jamienholloway: Excellent point! It's just as important to know what drugs *won't* work! #cancersm https://t.co/ozpQTMRriS
Amanda Haddock 🧬 @AmandaHaddock
@TheLizArmy @AshleySumrallMD @TimAllenMDJD It’s still far from common at a lot of hospitals. Out here in the middle, brain tumor patients don’t always get it offered to them, especially if they don’t have good insurance.
Christina Lizaso @btrfly12
RT @JFreemanDaily: Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tes…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T4: What biomarker tests should be run for which types of cancers? What is a liquid biopsy and when is useful? #cancersm
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @jamienholloway: Excellent point! It's just as important to know what drugs *won't* work! #cancersm https://t.co/ozpQTMRriS
Sarika Jain @drjainsp
T3 These drugs, like all drugs, have side effects, so beyond the needless cost, it is important to not treat patients with these molecular therapies if the biomarker testing shows that the drug would not benefit the patient. #cancersm
Dee Sparacio @womenofteal
RT @TimAllenMDJD: T4: What biomarker tests should be run for which types of cancers? What is a liquid biopsy and when is useful? #cancersm
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@HenningWillers @TimAllenMDJD In the future, I hope we have this to help w managing various #brainmets #btsm #cancersm (current ex: melanoma)
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @HenningWillers: @JFreemanDaily @NCCN T3 moreover #lungcancer patients with non-metastatic disease are even less often tested for these…
#LCSM Chat @lcsmchat
RT @drjainsp: T3: On the other hand, if a patient's biomarker testing does not show that that patient's cancer contains that therapeutic ta…
#LCSM Chat @lcsmchat
RT @HenningWillers: @JFreemanDaily @NCCN T3 moreover #lungcancer patients with non-metastatic disease are even less often tested for these…
#LCSM Chat @lcsmchat
RT @drjainsp: T3 These drugs, like all drugs, have side effects, so beyond the needless cost, it is important to not treat patients with th…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT [REDACTED USER]: #cancersm new hashtag chat to discuss about tumor biomarkers.
cunmarket.com @ebscbwi
RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im
Jamie Holloway, PhD @jamienholloway
I wouldn't go quite that far, but there are increasingly more treatment options that are more dependent on biomarker expression than tumor histology. #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AshleySumrallMD: @HenningWillers @TimAllenMDJD In the future, I hope we have this to help w managing various #brainmets #btsm #cancers
🅰🅼🆈🅷🅳🅴🅴🅺🅴🅽🅼🅳 @AmyHDeekenMD
RT @TimAllenMDJD: T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether…
#LCSM Chat @lcsmchat
RT @AshleySumrallMD: @HenningWillers @TimAllenMDJD In the future, I hope we have this to help w managing various #brainmets #btsm #cancers
Christina Lizaso @btrfly12
RT @TimAllenMDJD: T3: If the molecular biomarker testing shows that the patient's cancer contains the therapeutic target, then that patien…
Henning Willers, MD, FASTRO @HenningWillers
@subatomicdoc T3 good one, small cell cancer by IHC stains would make choice against surgery #lcsm #cancersm
#LCSM Chat @lcsmchat
RT @jamienholloway: I wouldn't go quite that far, but there are increasingly more treatment options that are more dependent on biomarker ex…
Amanda Haddock 🧬 @AmandaHaddock
Checking in late but trying to catch up. Coming in from #btsm community.#CancerSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @jamienholloway: I wouldn't go quite that far, but there are increasingly more treatment options that are more dependent on biomarker ex…
Moffitt Ph.D. Graduate Program @CancerBiol_PhD
@theNCI We now have a graduate major within our PhD program that trains students in the field of immunotherapy!! @MoffittResearch @MoffittNews
Dennis Keim @denniskeim
RT @TheLizArmy: @HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No lon…
Dennis Keim @denniskeim
RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im
Christina Lizaso @btrfly12
RT @drjainsp: T3 These drugs, like all drugs, have side effects, so beyond the needless cost, it is important to not treat patients with th…
#LCSM Chat @lcsmchat
RT @HenningWillers: @subatomicdoc T3 good one, small cell cancer by IHC stains would make choice against surgery #lcsm #cancersm
🅰🅼🆈🅷🅳🅴🅴🅺🅴🅽🅼🅳 @AmyHDeekenMD
RT @TimAllenMDJD: T2: Molecular biomarker testing involves laboratory tests that evaluate and identify the presence, on the surface of a c…
PF Anderson @pfanderson@disabled.social @pfanderson
@TheLizArmy @btrfly12 @steele_bob I wonder sometimes about general role of inflammation, which targets just about anything in the body. Sometimes treatments exacerbate underlying problems. They've known about eyes a long time > Ocular toxicity of antineoplastic agents. (1983) https://t.co/vhqn7tU9PU #CancerSM
Sarika Jain @drjainsp
T4 There are guidelines for what biomarker testing must be performed on different cancer types. https://t.co/0NmT5EaL4E #cancersm
Dennis Keim @denniskeim
RT @TheLizArmy: Great point! People facing a brain tumor--if diagnosed at a community hospital--might not be told about biomarker testing..…
Janet Freeman-Daily @JFreemanDaily
@TheLizArmy @TimAllenMDJD Pathology in #lungcancer still requires immunohistochemistry to determine type of lung cancer. Biomarkers are not yet useful in small cell lung cancer, except for clinical trial enrollment. #LCSM #cancersm
Bob Steele @steele_bob
RT @drjainsp: T4 There are guidelines for what biomarker testing must be performed on different cancer types. https://t.co/0NmT5EaL4E #canc
#LCSM Chat @lcsmchat
RT @pfanderson: @TheLizArmy @btrfly12 @steele_bob I wonder sometimes about general role of inflammation, which targets just about anything…
Christina Lizaso @btrfly12
RT @jamienholloway: I wouldn't go quite that far, but there are increasingly more treatment options that are more dependent on biomarker ex…
Israh Akhtar Khan @israhkhan
#CANCERSM more recently Fibroblast growth factor receptor 3 (FGFR3) mutations have been seen to occur in low grade bladder carcinoma and like EGFR is a tyrosine kinase receptor gene
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
RT @TimAllenMDJD: T4: What biomarker tests should be run for which types of cancers? What is a liquid biopsy and when is useful? #cancersm
Dennis Keim @denniskeim
RT @jamienholloway: T3: SO MANY OPTIONS can be identified through biomarkers. Hormone therapy, immunotherapy, targeted kinase inhibitors, a…
njbmd @njbmd
RT @drjainsp: T3 These drugs, like all drugs, have side effects, so beyond the needless cost, it is important to not treat patients with th…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @JFreemanDaily: @TheLizArmy @TimAllenMDJD Pathology in #lungcancer still requires immunohistochemistry to determine type of lung cancer.…
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @drjainsp: T4 There are guidelines for what biomarker testing must be performed on different cancer types. https://t.co/0NmT5EaL4E #canc
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AmandaHaddock: Checking in late but trying to catch up. Coming in from #btsm community.#CancerSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @HenningWillers: @subatomicdoc T3 good one, small cell cancer by IHC stains would make choice against surgery #lcsm #cancersm
#LCSM Chat @lcsmchat
RT @drjainsp: T4 There are guidelines for what biomarker testing must be performed on different cancer types. https://t.co/0NmT5EaL4E #canc
Dennis Keim @denniskeim
RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD I was diagnosed with a brain tumor in 2008 when checking for biomarkers was not part of stan…
Janet Freeman-Daily @JFreemanDaily
@HenningWillers Technically speaking, CT and PET scans are biomarkers. They would help determine whether surgery is possible. #LCSM #cancersm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @TheLizArmy @TimAllenMDJD Pathology in #lungcancer still requires immunohistochemistry to determine type of lung cancer.…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @israhkhan: #CANCERSM more recently Fibroblast growth factor receptor 3 (FGFR3) mutations have been seen to occur in low grade bladder c…
PF Anderson @pfanderson@disabled.social @pfanderson
@TimAllenMDJD Well said! We need a nice little cartoon or comic to illustrate this concept. A good visual #CancerSM
#LCSM Chat @lcsmchat
RT @israhkhan: #CANCERSM more recently Fibroblast growth factor receptor 3 (FGFR3) mutations have been seen to occur in low grade bladder c…
Julie Bonnett @Brjukala
YES!!!!!!!! So patients done endure treatments that WON’T work! Just as important as pre-selecting therapy they are likely to respond to!!
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T4: "Liquid biopsy" refers to molecular biomarker testing performed not on a patient's cancer tissue, but on cancer cells or cancer cell DNA or RNA that is floating in the blood stream. #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
RT @TimAllenMDJD: T4: What biomarker tests should be run for which types of cancers? What is a liquid biopsy and when is useful? #cancersm
Amanda Haddock 🧬 @AmandaHaddock
RT @AshleySumrallMD: @TimAllenMDJD T3 In #glioma, we use biomarkers as part of trial eligibilty. For ex: #MGMT status (although it is contr…
Sarika Jain @drjainsp
T4 For lung cancers, the minimum testing that must be performed is to look at the EGFR gene for mutations and ALK1 and ROS genes for rearrangements. Many pathologists examine other more recently recognized mutations. #cancersm
Dennis Keim @denniskeim
RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: @TimAllenMDJD Well said! We need a nice little cartoon or comic to illustrate this concept. A good visual #CancerSM
National Cancer Institute @theNCI
T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood or for pieces of DNA from tumor cells that are in the blood. #cancersm https://t.co/Qp4ziTm1ad
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @JFreemanDaily: @HenningWillers Technically speaking, CT and PET scans are biomarkers. They would help determine whether surgery is pos…
Pub Health Monitor @monitor_PH
RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood…
Dennis Keim @denniskeim
RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @TimAllenMDJD: T4: "Liquid biopsy" refers to molecular biomarker testing performed not on a patient's cancer tissue, but on cancer cell…
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@jamienholloway Depends on tumor type. Look at how “breast ca” is a multitude of diseases defined by ER, PR, H2N, and now PIK3CA. #bcsm #cancersm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @HenningWillers Technically speaking, CT and PET scans are biomarkers. They would help determine whether surgery is pos…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @drjainsp: T4 There are guidelines for what biomarker testing must be performed on different cancer types. https://t.co/0NmT5EaL4E #canc
José Gaxiola-López @GAXILO
RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: T4: "Liquid biopsy" refers to molecular biomarker testing performed not on a patient's cancer tissue, but on cancer cell…
Bob Steele @steele_bob
RT @pfanderson: @TheLizArmy @btrfly12 @steele_bob I wonder sometimes about general role of inflammation, which targets just about anything…
#LCSM Chat @lcsmchat
RT @drjainsp: T4 For lung cancers, the minimum testing that must be performed is to look at the EGFR gene for mutations and ALK1 and ROS ge…
National Cancer Institute @theNCI
T4 A #liquidbiopsy may be used to help find cancer at an early stage. #cancersm
Amanda Haddock 🧬 @AmandaHaddock
@theNCI Thanks for this!! Was just wondering if something like this existed!#cancersm
Sarika Jain @drjainsp
T4 For colon cancers, RAS gene testing to guide anti-EGFR therapy. BRAF mutational testing should also be performed for prognostic information. #cancersm
#LCSM Chat @lcsmchat
RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AshleySumrallMD: @jamienholloway Depends on tumor type. Look at how “breast ca” is a multitude of diseases defined by ER, PR, H2N, and…
Pub Health Monitor @monitor_PH
RT @theNCI: T4 A #liquidbiopsy may be used to help find cancer at an early stage. #cancersm
Henning Willers, MD, FASTRO @HenningWillers
RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood…
Christina Lizaso @btrfly12
RT @TimAllenMDJD: T4: "Liquid biopsy" refers to molecular biomarker testing performed not on a patient's cancer tissue, but on cancer cell…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AmandaHaddock: @theNCI Thanks for this!! Was just wondering if something like this existed!#cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @theNCI: T4 A #liquidbiopsy may be used to help find cancer at an early stage. #cancersm
Louella Vasquez @VasquezLouella
RT @theNCI: T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in commo…
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
@TimAllenMDJD In myeloma it would be great to have a liquid biopsy available instead of the painful bone marrow biopsy especially for repeat MRD testing. #CancerSM #MMSM
Liz Salmi @TheLizArmy
@AshleySumrallMD @TimAllenMDJD We could do a whole session on this at @NeuroOnc. 😞#SNO2019 #cancersm #btsm
@Jr121014921
RT @theNCI: T2 If you are interested in learning more about tumor markers, please see our expert-reviewed fact sheet on these biomarkers: h…
Sarika Jain @drjainsp
T4 For Breast cancers, the pathologist performs testing for estrogen receptor, progesterone receptor, and HER2 by immunohistochemistry. #cancersm
Janet Freeman-Daily @JFreemanDaily
@HenningWillers @subatomicdoc Not necessarily--surgery is still an option for some SCLC patients per NCCN guidelines. #LCSM #cancersm
Amanda Haddock 🧬 @AmandaHaddock
I get asked about different tumor markers all the time. Bookmarking this list!
National Cancer Institute @theNCI
T4 A liquid biopsy may also be used to help plan treatment or to find out how well treatment is working or if cancer has come back. Taking multiple samples of blood over time may also reveal the molecular changes taking place in a tumor. #cancersm #liquidbiopsy https://t.co/gaBX0Qvr3H
Pub Health Monitor @monitor_PH
RT @theNCI: T4 A liquid biopsy may also be used to help plan treatment or to find out how well treatment is working or if cancer has come b…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD We could do a whole session on this at @NeuroOnc. 😞#SNO2019 #cancersm #btsm
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@TimAllenMDJD Or CSF! T4 #btsm #cancersm https://t.co/4iKmHHEJXz
@RegisMarina
RT @TimAllenMDJD: T3: Therapeutic molecular biomarker tests identify a therapeutic target for which there is a currently available drug. #…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @JFreemanDaily: @HenningWillers @subatomicdoc Not necessarily--surgery is still an option for some SCLC patients per NCCN guidelines. #L
Israh Akhtar Khan @israhkhan
#CANCERSM sadly not much is known about the genetics, biomarkers or prognostic indicators of this deadly cancer of the lung (small cell carcinoma ) https://t.co/EtuD0NG1Ni
#LCSM Chat @lcsmchat
RT @drjainsp: T4 For Breast cancers, the pathologist performs testing for estrogen receptor, progesterone receptor, and HER2 by immunohisto…
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @HenningWillers @subatomicdoc Not necessarily--surgery is still an option for some SCLC patients per NCCN guidelines. #L
#LCSM Chat @lcsmchat
RT @theNCI: T4 A liquid biopsy may also be used to help plan treatment or to find out how well treatment is working or if cancer has come b…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AshleySumrallMD: @TimAllenMDJD Or CSF! T4 #btsm #cancersm https://t.co/4iKmHHEJXz
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@TheLizArmy @TimAllenMDJD @NeuroOnc And we should.
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @israhkhan: #CANCERSM sadly not much is known about the genetics, biomarkers or prognostic indicators of this deadly cancer of the lung…
#LCSM Chat @lcsmchat
RT @AshleySumrallMD: @TimAllenMDJD Or CSF! T4 #btsm #cancersm https://t.co/4iKmHHEJXz
#LCSM Chat @lcsmchat
RT @israhkhan: #CANCERSM sadly not much is known about the genetics, biomarkers or prognostic indicators of this deadly cancer of the lung…
National Cancer Institute @theNCI
T4 From NCI’s Cancer Currents blog last year: Liquid biopsy may predict the risk of breast cancer returning years later: https://t.co/zuL4GnA0CV #liquidbiopsy #cancersm
Peggy Dennis @peggyddennis
T4 Why stop on a just a few or only those actionable?Check all possible so as treatments become available new biopsy is not need. #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
@theNCI It's pretty amazing these days what can be done with "it's just a blood test" #CancerSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T4: Liquid biopsy is used in cases where a biopsy of a patient's cancer cannot be performed because the patient is too ill to tolerate the diagnostic procedure, or where the cancer site is difficult to access with a biopsy e.g., a lesion deep inside the body. #cancersm
Christina Lizaso @btrfly12
RT @MyelomaTeacher: @TimAllenMDJD In myeloma it would be great to have a liquid biopsy available instead of the painful bone marrow biopsy…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @israhkhan: #CANCERSM sadly not much is known about the genetics, biomarkers or prognostic indicators of this deadly cancer of the lung…
Bob Steele @steele_bob
RT @israhkhan: #CANCERSM sadly not much is known about the genetics, biomarkers or prognostic indicators of this deadly cancer of the lung…
@naborala
RT @theNCI: T4 From NCI’s Cancer Currents blog last year: Liquid biopsy may predict the risk of breast cancer returning years later: https:…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @theNCI: T4 A liquid biopsy may also be used to help plan treatment or to find out how well treatment is working or if cancer has come b…
National Cancer Institute @theNCI
RT @TimAllenMDJD: T4: Liquid biopsy is used in cases where a biopsy of a patient's cancer cannot be performed because the patient is too i…
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
@JFreemanDaily @HenningWillers True, but it still may play a role in opting for surgery. Also plays a role in the conversation about prophylactic cranial irradiation #cancersm #lcsm
Eden Lake @EdenLake
RT @sabinbmotwanimd: Also important not only to find therapeutic biomarkers but also markers of resistance #cancersm
Nick Petosky @pizzapicklespur
@theNCI PCR for MPMV & EBV?
Alicia C. Staley @stales
RT @TimAllenMDJD: T3: What treatment options can be identified through biomarker testing? #cancersm #cancersm
yetAnotherName @glostaMAssachu
RT @israhkhan: #CANCERSM sadly not much is known about the genetics, biomarkers or prognostic indicators of this deadly cancer of the lung…
Pallavi Tiwari @Pallavi_Tiwari
RT @theNCI: T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in commo…
National Cancer Institute @theNCI
T4 And here’s an overview from 2017 of the evolving science around liquid biopsies and the important research questions: https://t.co/zqj48vhMbG #liquidbiopsy #cancersm
Andrea @BraveBosom
RT @stales: RT @TimAllenMDJD: T3: What treatment options can be identified through biomarker testing? #cancersm #cancersm
Henning Willers, MD, FASTRO @HenningWillers
@JFreemanDaily @subatomicdoc T3 correct, for the rare stage I SCLC finding this at the time of needle biopsy or wedge resection this is still a good option! (stage II more controversial) #cancersm #lcsm
Jamie Holloway, PhD @jamienholloway
T4: I love the quote about liquid biopsies-- It's like looking for a needle in a haystack. If you find a needle, it's a needle. But if you don't find the needle, it doesn't mean one's not there. A negative result always needs to be followed up by testing tissue. #cancersm
Kristina Kotlus @KristinaKotlus
RT @TimAllenMDJD: T4: What biomarker tests should be run for which types of cancers? What is a liquid biopsy and when is useful? #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Glad you are here, @EdenLake! #cancersm
#LCSM Chat @lcsmchat
RT @theNCI: T4 From NCI’s Cancer Currents blog last year: Liquid biopsy may predict the risk of breast cancer returning years later: https:…
#LCSM Chat @lcsmchat
RT @peggyddennis: T4 Why stop on a just a few or only those actionable?Check all possible so as treatments become available new biopsy is n…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @stales: RT @TimAllenMDJD: T3: What treatment options can be identified through biomarker testing? #cancersm #cancersm
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @TimAllenMDJD: T4: Liquid biopsy is used in cases where a biopsy of a patient's cancer cannot be performed because the patient is too i…
Noel Del Valle @chitowncopr64
RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @subatomicdoc: @JFreemanDaily @HenningWillers True, but it still may play a role in opting for surgery. Also plays a role in the convers…
#LCSM Chat @lcsmchat
RT @pfanderson: @theNCI It's pretty amazing these days what can be done with "it's just a blood test" #CancerSM
Sarika Jain @drjainsp
RT @TimAllenMDJD: T4: Liquid biopsy is used in cases where a biopsy of a patient's cancer cannot be performed because the patient is too i…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: @theNCI It's pretty amazing these days what can be done with "it's just a blood test" #CancerSM
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: T4: Liquid biopsy is used in cases where a biopsy of a patient's cancer cannot be performed because the patient is too i…
#LCSM Chat @lcsmchat
RT @subatomicdoc: @JFreemanDaily @HenningWillers True, but it still may play a role in opting for surgery. Also plays a role in the convers…
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
RT @HenningWillers: @JFreemanDaily @subatomicdoc T3 correct, for the rare stage I SCLC finding this at the time of needle biopsy or wedge r…
c0nc0rdance @c0nc0rdance
@TimAllenMDJD T4: A liquid biopsy is testing done in a biofluid like blood plasma, where DNA or protein from the tumor can be found. It avoids the cost and risk of surgical biopsy, and can better represent the DNA or protein makeup of diverse tumors. #CancerSM https://t.co/zQmvg33g5v
#LCSM Chat @lcsmchat
RT @HenningWillers: @JFreemanDaily @subatomicdoc T3 correct, for the rare stage I SCLC finding this at the time of needle biopsy or wedge r…
#LCSM Chat @lcsmchat
RT @jamienholloway: T4: I love the quote about liquid biopsies-- It's like looking for a needle in a haystack. If you find a needle, it's a…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @HenningWillers: @JFreemanDaily @subatomicdoc T3 correct, for the rare stage I SCLC finding this at the time of needle biopsy or wedge r…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @c0nc0rdance: @TimAllenMDJD T4: A liquid biopsy is testing done in a biofluid like blood plasma, where DNA or protein from the tumor ca…
Sabin Motwani @sabinbmotwanimd
T4 interpretation of biomarker test must be easy to interpret by pathology. Not as simple as positive or negative or methylated vs unmethylated. Eg MGMT #cancersm
Janet Freeman-Daily @JFreemanDaily
@israhkhan We have lots of data about mutations in SCLC. Unfortunately, we haven't identified one or two predominant mutations to target. SCLC is really hetereogenous. #LCSM #cancersm
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
IM still trying to understand the complexity of biomarker testing. Would FISH testing on BMB aspirate to determine risk stratification in myeloma be considered prognostic biomarker testing? #cancersm #MMSM
PF Anderson @pfanderson@disabled.social @pfanderson
MIT Tech Review: Liquid Biopsy Fast DNA-sequencing machines are leading to simple blood tests for cancer. (2015) https://t.co/hw4kQVftKq #CancerSM
Henning Willers, MD, FASTRO @HenningWillers
RT @jamienholloway: T4: I love the quote about liquid biopsies-- It's like looking for a needle in a haystack. If you find a needle, it's a…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T4: Liquid biopsy is relatively new, and so not all laboratories perform it. This is a rapidly growing area but at this time molecular testing performed of the cancer tissue itself is better than liquid biopsy at the time of primary diagnosis. #cancersm
Henning Willers, MD, FASTRO @HenningWillers
RT @c0nc0rdance: @TimAllenMDJD T4: A liquid biopsy is testing done in a biofluid like blood plasma, where DNA or protein from the tumor ca…
Jen Buhay, PhD 💙 🥥🌴 @JenBuhayPhD
RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m…
#LCSM Chat @lcsmchat
RT @c0nc0rdance: @TimAllenMDJD T4: A liquid biopsy is testing done in a biofluid like blood plasma, where DNA or protein from the tumor ca…
Christina Lizaso @btrfly12
RT @jamienholloway: T4: I love the quote about liquid biopsies-- It's like looking for a needle in a haystack. If you find a needle, it's a…
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @jamienholloway: T4: I love the quote about liquid biopsies-- It's like looking for a needle in a haystack. If you find a needle, it's a…
Liz Salmi @TheLizArmy
@AshleySumrallMD @TimAllenMDJD @NeuroOnc Before [REDACTED USER] came out with the 2016 CNS reclassification, I stalked a #neuropath conference on Twitter to learn all about it... then I blogged about it. Ladies & gentle-persons: This is @TheLizArmy circa 2015. https://t.co/WKthTX0pNy #cancersm #btsm #memories
Jamie Holloway, PhD @jamienholloway
@MyelomaTeacher You've got it, Cindy! #CANCERSM
yetAnotherName @glostaMAssachu
RT @jamienholloway: T4: I love the quote about liquid biopsies-- It's like looking for a needle in a haystack. If you find a needle, it's a…
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: T4: Liquid biopsy is relatively new, and so not all laboratories perform it. This is a rapidly growing area but at this…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD @NeuroOnc Before [REDACTED USER] came out with the 2016 CNS reclassification, I stalked a #neuropath co…
#LCSM Chat @lcsmchat
RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD @NeuroOnc Before [REDACTED USER] came out with the 2016 CNS reclassification, I stalked a #neuropath co…
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
What about the role of WHERE we sample? Do biomarker findings have different implications if biopsy taken from the primary tumor or a site of disease spread? #cancersm
Israh Akhtar Khan @israhkhan
#CANCERSM : Adenocarcinoma of lung with leipidic pattern is a good prognosis carcinoma. Similarly Alk positive adenocarcinoma is known to occur in Asian females who are non-smokers https://t.co/086OyTmXbG
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@peggyddennis @TimAllenMDJD The issue is that tumors evolve. Multiple pubs show that biomarkers change. Look at #BATTLE in #lcsm #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
RT @TimAllenMDJD: T4: Liquid biopsy is relatively new, and so not all laboratories perform it. This is a rapidly growing area but at this…
National Cancer Institute @theNCI
RT @subatomicdoc: What about the role of WHERE we sample? Do biomarker findings have different implications if biopsy taken from the primar…
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @JFreemanDaily: @israhkhan We have lots of data about mutations in SCLC. Unfortunately, we haven't identified one or two predominant mut…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @subatomicdoc: What about the role of WHERE we sample? Do biomarker findings have different implications if biopsy taken from the primar…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD @NeuroOnc Before [REDACTED USER] came out with the 2016 CNS reclassification, I stalked a #neuropath co…
Alicia C. Staley @stales
RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD @NeuroOnc Before [REDACTED USER] came out with the 2016 CNS reclassification, I stalked a #neuropath co…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
@jamienholloway YEAH!
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AshleySumrallMD: @peggyddennis @TimAllenMDJD The issue is that tumors evolve. Multiple pubs show that biomarkers change. Look at #BATTL
Dennis Keim @denniskeim
@TheLizArmy @AshleySumrallMD @TimAllenMDJD Seems like that new and relevant tests should be standard operating procedure for checkups. I had what I presume was standard breast cancer pathology for 2013 and BRCA and Oncotype DX done but I imagine there are some new things that might be worthwhile knowing. #bcsm #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @israhkhan: #CANCERSM : Adenocarcinoma of lung with leipidic pattern is a good prognosis carcinoma. Similarly Alk positive adenocarcinom…
Bob Steele @steele_bob
RT @AshleySumrallMD: @peggyddennis @TimAllenMDJD The issue is that tumors evolve. Multiple pubs show that biomarkers change. Look at #BATTL
Amanda Haddock 🧬 @AmandaHaddock
@theNCI Reading the description, I see that there is a lot not included. Is there a resource showing more mutations - even those not actionable?
Frufruit @_lulyf
RT @drjainsp: T4 For Breast cancers, the pathologist performs testing for estrogen receptor, progesterone receptor, and HER2 by immunohisto…
Liz Salmi @TheLizArmy
@AmandaHaddock @AshleySumrallMD @TimAllenMDJD Remember the hashtag, Amanda! #cancersm #btsm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T5: Can and should patients pursue biomarker testing for treatment options if their doctor does not offer it? #cancersm
Christina Lizaso @btrfly12
@itsthebunk Waving hello Liza and thanks for all your do for patients! :) #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
@TheLizArmy @AshleySumrallMD @TimAllenMDJD @NeuroOnc [REDACTED USER] You are (and were) doing important work. Thank you!
Amanda Haddock 🧬 @AmandaHaddock
RT @TheLizArmy: Great point! People facing a brain tumor--if diagnosed at a community hospital--might not be told about biomarker testing..…
#LCSM Chat @lcsmchat
RT @israhkhan: #CANCERSM : Adenocarcinoma of lung with leipidic pattern is a good prognosis carcinoma. Similarly Alk positive adenocarcinom…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @israhkhan: #CANCERSM : Adenocarcinoma of lung with leipidic pattern is a good prognosis carcinoma. Similarly Alk positive adenocarcinom…
Jen Buhay, PhD 💙 🥥🌴 @JenBuhayPhD
RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD I was diagnosed with a brain tumor in 2008 when checking for biomarkers was not part of stan…
#LCSM Chat @lcsmchat
RT @AshleySumrallMD: @peggyddennis @TimAllenMDJD The issue is that tumors evolve. Multiple pubs show that biomarkers change. Look at #BATTL
Janet Freeman-Daily @JFreemanDaily
@peggyddennis There are tens of thousands of possible mutations in human DNA. It's not possible to catch them all in one test. Best to design the test to look for those mutations that have best chance of helping to guide treatment. #LCSM #cancersm
Alicia C. Staley @stales
RT @TimAllenMDJD: T4: "Liquid biopsy" refers to molecular biomarker testing performed not on a patient's cancer tissue, but on cancer cell…
Rachael @PollywogPrinces
RT @c0nc0rdance: #CancerSM is a Twitter chat discussing the basics of biomarker testing for cancer. If it's a topic you're interested in,…
Alicia C. Staley @stales
RT @JFreemanDaily: @HenningWillers Technically speaking, CT and PET scans are biomarkers. They would help determine whether surgery is pos…
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: T5: Can and should patients pursue biomarker testing for treatment options if their doctor does not offer it? #cancersm
Alicia C. Staley @stales
RT @JFreemanDaily: @TheLizArmy @TimAllenMDJD Pathology in #lungcancer still requires immunohistochemistry to determine type of lung cancer.…
PF Anderson @pfanderson@disabled.social @pfanderson
@subatomicdoc Excellent question! So much we still need to learn! #CancerSM
PF Anderson @pfanderson@disabled.social @pfanderson
RT @JFreemanDaily: @peggyddennis There are tens of thousands of possible mutations in human DNA. It's not possible to catch them all in one…
Prathyusha Konda ✨ @labratprats
RT @subatomicdoc: What about the role of WHERE we sample? Do biomarker findings have different implications if biopsy taken from the primar…
Jen Buhay, PhD 💙 🥥🌴 @JenBuhayPhD
RT @JFreemanDaily: Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tes…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: @subatomicdoc Excellent question! So much we still need to learn! #CancerSM
Amanda Haddock 🧬 @AmandaHaddock
@TheLizArmy @AshleySumrallMD @TimAllenMDJD Lol, I knew you were gonna ding me on that! It’s been a long, emotional day. I’ll try to do better.😬
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
RT @AshleySumrallMD: @peggyddennis @TimAllenMDJD The issue is that tumors evolve. Multiple pubs show that biomarkers change. Look at #BATTL
Aaron Maestri @aaronmaestri
RT @JFreemanDaily: @TheLizArmy @TimAllenMDJD Pathology in #lungcancer still requires immunohistochemistry to determine type of lung cancer.…
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @peggyddennis There are tens of thousands of possible mutations in human DNA. It's not possible to catch them all in one…
National Cancer Institute @theNCI
@MyelomaTeacher Good question. We'll check with our experts and get back to you tomorrow if that's okay.
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
@AshleySumrallMD @TimAllenMDJD There is some discordance in ER/PR/Her2 in breast cancer. Here is an example between the primary tumor and nodal metastases: https://t.co/MqhpcGuYfU What other diseases does it differ? #cancersm #bcsm
Christina Lizaso @btrfly12
RT @TimAllenMDJD: T5: Can and should patients pursue biomarker testing for treatment options if their doctor does not offer it? #cancersm
Jen Buhay, PhD 💙 🥥🌴 @JenBuhayPhD
RT @jamienholloway: Excellent point! It's just as important to know what drugs *won't* work! #cancersm https://t.co/ozpQTMRriS
Jamie Holloway, PhD @jamienholloway
T5: Easiest tweetchat answer ever. #cancersm https://t.co/9jxX9jnvIW
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@denniskeim @TheLizArmy @TimAllenMDJD Oncologists interprets use of new biomarkers differently. By the time the biomarkers hit guidelines, they may be “old news”
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
RT @TimAllenMDJD: T5: Can and should patients pursue biomarker testing for treatment options if their doctor does not offer it? #cancersm
@UppityCancerP
RT @subatomicdoc: @AshleySumrallMD @TimAllenMDJD There is some discordance in ER/PR/Her2 in breast cancer. Here is an example between the p…
WhatFreshHello @whatfreshhello
RT @theNCI: T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in commo…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
RT @TimAllenMDJD: T5: Can and should patients pursue biomarker testing for treatment options if their doctor does not offer it? #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @jamienholloway: T5: Easiest tweetchat answer ever. #cancersm https://t.co/xPHAS32q70 https://t.co/9jxX9jnvIW
c0nc0rdance @c0nc0rdance
@TimAllenMDJD T4: Since we can do blood draws for liquid biopsy easily, it can improve the frequency with which an oncologists checks on the status of cancer treatments to detect as early as possible the emergence of resistance or recurrence #CancerSM https://t.co/0meqKJgon8
Dennis Keim @denniskeim
RT @AshleySumrallMD: @peggyddennis @TimAllenMDJD The issue is that tumors evolve. Multiple pubs show that biomarkers change. Look at #BATTL
National Cancer Institute @theNCI
T5 NCI does not have guidelines for the use of tumor markers. However, some national and international organizations have guidelines for the use of tumor markers for some types of cancer: https://t.co/o85pqHZKoy #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T5: Molecular testing and molecular therapy has become the standard of care for many cancers. Most doctors are performing the recommended molecular testing on particular types of cancer. #cancersm
Pub Health Monitor @monitor_PH
RT @theNCI: T5 NCI does not have guidelines for the use of tumor markers. However, some national and international organizations have guide…
Dennis Keim @denniskeim
RT @TimAllenMDJD: T5: Can and should patients pursue biomarker testing for treatment options if their doctor does not offer it? #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
@JFreemanDaily @peggyddennis I use the analogies of cherry picking (looking at just the most likely & essential ones to save time/cost) and apple harvesting (shaking the tree until everything falls off) #CancerSM
Janet Freeman-Daily @JFreemanDaily
@AshleySumrallMD @peggyddennis @TimAllenMDJD And cancer evolves to develop resistance to targeted therapies. That's why rebiopsy is now more common after cancer progression in NSCLC. #lcsm #cancerssm
PF Anderson @pfanderson@disabled.social @pfanderson
RT @c0nc0rdance: @TimAllenMDJD T4: Since we can do blood draws for liquid biopsy easily, it can improve the frequency with which an oncolo…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
@TimAllenMDJD I think biomarker testing is a smart thing to do, but does insurance cover it? #MMSM
Jen Buhay, PhD 💙 🥥🌴 @JenBuhayPhD
RT @AshleySumrallMD: @TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as w…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @subatomicdoc: @AshleySumrallMD @TimAllenMDJD There is some discordance in ER/PR/Her2 in breast cancer. Here is an example between the p…
#LCSM Chat @lcsmchat
RT @jamienholloway: T5: Easiest tweetchat answer ever. #cancersm https://t.co/xPHAS32q70 https://t.co/9jxX9jnvIW
#LCSM Chat @lcsmchat
RT @c0nc0rdance: @TimAllenMDJD T4: Since we can do blood draws for liquid biopsy easily, it can improve the frequency with which an oncolo…
Henning Willers, MD, FASTRO @HenningWillers
@TimAllenMDJD T5 absolutely! doctor should always point out all possible options even if not available at his/her own institution #cancersm
Amanda Haddock 🧬 @AmandaHaddock
RT @jamienholloway: T5: Easiest tweetchat answer ever. #cancersm https://t.co/xPHAS32q70 https://t.co/9jxX9jnvIW
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @HenningWillers: @TimAllenMDJD T5 absolutely! doctor should always point out all possible options even if not available at his/her own i…
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@subatomicdoc @TimAllenMDJD I love the paper illustrating different markers for #brainmets from #breastca. Can’t reference it rt now #bcsm
Janet Freeman-Daily @JFreemanDaily
@AshleySumrallMD @peggyddennis @TimAllenMDJD And cancer evolves to develop resistance to targeted therapies. That's why rebiopsy is now more common after cancer progression in NSCLC. #lcsm #cancersm
Christina Lizaso @btrfly12
T5: As @JFreemanDaily bought up, the NCCN guidelines are a great resource and an excellent place for patients to find out what the current recommendations are and ask questions of their doc's if there is a variance https://t.co/X5OVXPY9g6 #cancersm
@darrowbythirsk
RT @theNCI: T5 NCI does not have guidelines for the use of tumor markers. However, some national and international organizations have guide…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @JFreemanDaily: @AshleySumrallMD @peggyddennis @TimAllenMDJD And cancer evolves to develop resistance to targeted therapies. That's why…
Alicia C. Staley @stales
RT @TimAllenMDJD: T5: Molecular testing and molecular therapy has become the standard of care for many cancers. Most doctors are performin…
Alicia C. Staley @stales
RT @theNCI: T5 NCI does not have guidelines for the use of tumor markers. However, some national and international organizations have guide…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @JFreemanDaily: @AshleySumrallMD @peggyddennis @TimAllenMDJD And cancer evolves to develop resistance to targeted therapies. That's why…
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
@jamienholloway Agreed! #cancersm
Sarika Jain @drjainsp
T5 The basic question to ask your doctor is "Given my diagnosis, is molecular biomarker testing is right for me?" You can read about guidelines which are specifically designed for patients at https://t.co/yyMAKwn2RK #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
RT @btrfly12: T5: As @JFreemanDaily bought up, the NCCN guidelines are a great resource and an excellent place for patients to find out wha…
Dennis Keim @denniskeim
RT @jamienholloway: T5: Easiest tweetchat answer ever. #cancersm https://t.co/xPHAS32q70 https://t.co/9jxX9jnvIW
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
#cancersm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @AshleySumrallMD @peggyddennis @TimAllenMDJD And cancer evolves to develop resistance to targeted therapies. That's why…
PF Anderson @pfanderson@disabled.social @pfanderson
@btrfly12 @JFreemanDaily We used to have https://t.co/vix57AVfiK for parts of this. Such a loss #CancerSM
#LCSM Chat @lcsmchat
RT @drjainsp: T5 The basic question to ask your doctor is "Given my diagnosis, is molecular biomarker testing is right for me?" You can rea…
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@subatomicdoc @TimAllenMDJD Colon. https://t.co/l7IWBkHDBW #cancersm
Israh Akhtar Khan @israhkhan
#CANCERSM Personalized oncology is based on biomarkers (driver mutations), stage & histology. In lung Ca major biomarkers are : EGFR (10-15% NSCLCs), ALK (2-7%), ROS-1 (1-2%), K-ras (15-30%) are generally mutually exclusive. Cytology material are good substrates for this testing
PF Anderson @pfanderson@disabled.social @pfanderson
RT @drjainsp: T5 The basic question to ask your doctor is "Given my diagnosis, is molecular biomarker testing is right for me?" You can rea…
Christina Lizaso @btrfly12
T5: Second opinions are almost always a good idea - especially in cancer. Seek doc's with high case volume of your specific type of cancer. You are you own best advocate and the science is changing fast. #cancersm
Henning Willers, MD, FASTRO @HenningWillers
RT @btrfly12: T5: As @JFreemanDaily bought up, the NCCN guidelines are a great resource and an excellent place for patients to find out wha…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @DarcyBurbage: @jamienholloway Agreed! #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
T5: It's always a good idea to ask your doctor about molecular testing; but given the confusion in this rapidly changing area, it may be difficult to know what to ask your doctor. Feel free to call your pathologist and discuss! #cancersm
Henning Willers, MD, FASTRO @HenningWillers
RT @JFreemanDaily: @AshleySumrallMD @peggyddennis @TimAllenMDJD And cancer evolves to develop resistance to targeted therapies. That's why…
Jen Buhay, PhD 💙 🥥🌴 @JenBuhayPhD
RT @jamienholloway: T5: Easiest tweetchat answer ever. #cancersm https://t.co/xPHAS32q70 https://t.co/9jxX9jnvIW
@UppityCancerP
RT @pfanderson: @btrfly12 @JFreemanDaily We used to have https://t.co/vix57AVfiK for parts of this. Such a loss #CancerSM
#LCSM Chat @lcsmchat
RT @pfanderson: @btrfly12 @JFreemanDaily We used to have https://t.co/vix57AVfiK for parts of this. Such a loss #CancerSM
#LCSM Chat @lcsmchat
RT @AshleySumrallMD: @subatomicdoc @TimAllenMDJD Colon. https://t.co/l7IWBkHDBW #cancersm
#LCSM Chat @lcsmchat
RT @israhkhan: #CANCERSM Personalized oncology is based on biomarkers (driver mutations), stage & histology. In lung Ca major biomarkers ar…
Sandra Spivey @SpiveySandra
Coming late to the conversation. Any discussion about cost to patient for these tests? I was surprised to find I had a $3,000 copay *after* my cfDNA test was performed. #cancersm
Amanda Haddock 🧬 @AmandaHaddock
@c0nc0rdance @TimAllenMDJD T4: Are there solid mass tumors that are using liquid biopsy for diagnosis/progression information? As I understand it, it isn’t an approved clinical tool for brain tumors yet. #cancersm
meghna mehta @meghnamehta
@TimAllenMDJD @theNCI Or where good interventional rad is not available to do biopsy
Christina Lizaso @btrfly12
RT @JFreemanDaily: @AshleySumrallMD @peggyddennis @TimAllenMDJD And cancer evolves to develop resistance to targeted therapies. That's why…
#LCSM Chat @lcsmchat
RT @btrfly12: T5: Second opinions are almost always a good idea - especially in cancer. Seek doc's with high case volume of your specific t…
Liz Salmi @TheLizArmy
RT @jamienholloway: T5: Easiest tweetchat answer ever. #cancersm https://t.co/xPHAS32q70 https://t.co/9jxX9jnvIW
Henning Willers, MD, FASTRO @HenningWillers
RT @btrfly12: T5: Second opinions are almost always a good idea - especially in cancer. Seek doc's with high case volume of your specific t…
Adam L. Booth, MD @ALBoothMD
RT @theNCI: T5 NCI does not have guidelines for the use of tumor markers. However, some national and international organizations have guide…
Bob Steele @steele_bob
RT @AshleySumrallMD: @subatomicdoc @TimAllenMDJD Colon. https://t.co/l7IWBkHDBW #cancersm
Sara Elizabeth Siegler @sesiegler
@subatomicdoc @pfanderson @AshleySumrallMD @TimAllenMDJD Antigen expression loss is pretty common in mets and may be treatment induced.
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AmandaHaddock: @c0nc0rdance @TimAllenMDJD T4: Are there solid mass tumors that are using liquid biopsy for diagnosis/progression inform…
Liz Salmi @TheLizArmy
RT @btrfly12: T5: Second opinions are almost always a good idea - especially in cancer. Seek doc's with high case volume of your specific t…
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@subatomicdoc @TimAllenMDJD GI. @LevineCancer https://t.co/FzYiYlJXdN #cancersm
Janet Freeman-Daily @JFreemanDaily
#lungcancer treatments are evolving so fast that even LC specialists have trouble keeping up--dozens of new tx approvals in just past 5 years. If your doctor does not mention biomarker testing for you NSCLC, ASK! It's stand of care! #lcsm #cancersm
meghna mehta @meghnamehta
This is incredible. That’s why we need to have affordable liquid biopsies
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @israhkhan: #CANCERSM Personalized oncology is based on biomarkers (driver mutations), stage & histology. In lung Ca major biomarkers ar…
Henning Willers, MD, FASTRO @HenningWillers
@TimAllenMDJD T5 how do you call your pathologist? #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AshleySumrallMD: @subatomicdoc @TimAllenMDJD Colon. https://t.co/l7IWBkHDBW #cancersm
Alicia C. Staley @stales
RT @AshleySumrallMD: @peggyddennis @TimAllenMDJD The issue is that tumors evolve. Multiple pubs show that biomarkers change. Look at #BATTL
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: @btrfly12 @JFreemanDaily We used to have https://t.co/vix57AVfiK for parts of this. Such a loss #CancerSM
PF Anderson @pfanderson@disabled.social @pfanderson
@drjainsp When someone asks me about a new diagnosis, one of the first things I like to do is search for "questions to ask your doctor" "new diagnosis" [X = topic/diagnosis/disease/procedure/surgery] So often I find very helpful tips! #CancerSM #Medlibs
Alicia C. Staley @stales
RT @israhkhan: #CANCERSM : Adenocarcinoma of lung with leipidic pattern is a good prognosis carcinoma. Similarly Alk positive adenocarcinom…
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
RT @AshleySumrallMD: @subatomicdoc @TimAllenMDJD Colon. https://t.co/l7IWBkHDBW #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @JFreemanDaily: #lungcancer treatments are evolving so fast that even LC specialists have trouble keeping up--dozens of new tx approvals…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AshleySumrallMD: @subatomicdoc @TimAllenMDJD GI. @LevineCancer https://t.co/FzYiYlJXdN #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
RT @btrfly12: T5: Second opinions are almost always a good idea - especially in cancer. Seek doc's with high case volume of your specific t…
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@subatomicdoc @TimAllenMDJD And #melanoma. https://t.co/nQG9QlN2ff #cancersm
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
@AshleySumrallMD @TimAllenMDJD Cool thanks Ashley! #cancersm
Alicia C. Staley @stales
@subatomicdoc great question that I've always wondered about. #CancerSm
Alicia C. Staley @stales
RT @pfanderson: MIT Tech Review: Liquid Biopsy Fast DNA-sequencing machines are leading to simple blood tests for cancer. (2015) https://t.…
#LCSM Chat @lcsmchat
RT @SpiveySandra: Coming late to the conversation. Any discussion about cost to patient for these tests? I was surprised to find I had a…
Jen Buhay, PhD 💙 🥥🌴 @JenBuhayPhD
RT @JFreemanDaily: #lungcancer treatments are evolving so fast that even LC specialists have trouble keeping up--dozens of new tx approvals…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
I don't think myeloma has any established therapeutic biomarkers. @theMMRF MyDrug trial is trying to match certain mutations to type of therapy #MMSM https://t.co/L6kJFkEjIH #cancerSM
Alicia C. Staley @stales
RT @sabinbmotwanimd: T4 interpretation of biomarker test must be easy to interpret by pathology. Not as simple as positive or negative or m…
#LCSM Chat @lcsmchat
RT @AmandaHaddock: @c0nc0rdance @TimAllenMDJD T4: Are there solid mass tumors that are using liquid biopsy for diagnosis/progression inform…
Liz Salmi @TheLizArmy
@btrfly12 Can someone who is really great at Storify just Storify this tweet chat so I can share that Storify with everyone diagnosed with a malignancy yesterday, today and tomorrow??!!! Paging @BraveBosom. #cancersm #btsm
Adam L. Booth, MD @ALBoothMD
RT @subatomicdoc: What about the role of WHERE we sample? Do biomarker findings have different implications if biopsy taken from the primar…
#LCSM Chat @lcsmchat
RT @AshleySumrallMD: @subatomicdoc @TimAllenMDJD GI. @LevineCancer https://t.co/FzYiYlJXdN #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
@HenningWillers @TimAllenMDJD Exactly! Are pathologists accessible to the public? How do you find out who is "your" pathologist? #CancerSM
Janet Freeman-Daily @JFreemanDaily
@AmandaHaddock @c0nc0rdance @TimAllenMDJD We have one liquid biopsy that is FDA approved for detecting a specific mutation in EGFR+ #lungcancer. #LCSM #cancersm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: #lungcancer treatments are evolving so fast that even LC specialists have trouble keeping up--dozens of new tx approvals…
Jamie Holloway, PhD @jamienholloway
@AmandaHaddock @c0nc0rdance @TimAllenMDJD There is an FDA-approved companion diagnostic in lung cancer. But still, a negative liquid biopsy needs to reflex to tumor tissue analysis because not all tumors shed enough DNA. #cancersm
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@subatomicdoc @TimAllenMDJD Love the work we are doing w @carisls POA.
PF Anderson @pfanderson@disabled.social @pfanderson
RT @SpiveySandra: Coming late to the conversation. Any discussion about cost to patient for these tests? I was surprised to find I had a…
#LCSM Chat @lcsmchat
RT @pfanderson: @HenningWillers @TimAllenMDJD Exactly! Are pathologists accessible to the public? How do you find out who is "your" patholo…
#LCSM Chat @lcsmchat
RT @pfanderson: @drjainsp When someone asks me about a new diagnosis, one of the first things I like to do is search for "questions to ask…
#LCSM Chat @lcsmchat
RT @AshleySumrallMD: @subatomicdoc @TimAllenMDJD And #melanoma. https://t.co/nQG9QlN2ff #cancersm
Henning Willers, MD, FASTRO @HenningWillers
@JFreemanDaily i have definitely trouble keeping up!! #lcsm #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Get your pathology report and usually there's a phone number. If not, your hospital or clinic should be able to provide it. #cancersm
Dennis Keim @denniskeim
RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD @NeuroOnc Before [REDACTED USER] came out with the 2016 CNS reclassification, I stalked a #neuropath co…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @JFreemanDaily: @AmandaHaddock @c0nc0rdance @TimAllenMDJD We have one liquid biopsy that is FDA approved for detecting a specific mutati…
Jen Buhay, PhD 💙 🥥🌴 @JenBuhayPhD
RT @jamienholloway: @AmandaHaddock @c0nc0rdance @TimAllenMDJD There is an FDA-approved companion diagnostic in lung cancer. But still, a ne…
Henning Willers, MD, FASTRO @HenningWillers
RT @JFreemanDaily: @AmandaHaddock @c0nc0rdance @TimAllenMDJD We have one liquid biopsy that is FDA approved for detecting a specific mutati…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: @HenningWillers @TimAllenMDJD Exactly! Are pathologists accessible to the public? How do you find out who is "your" patholo…
c0nc0rdance @c0nc0rdance
@AmandaHaddock @TimAllenMDJD Yes, but only one is IVD. There's also a large and expanding Lab Developed Test market for liquid biopsy in solid tumors. https://t.co/5rQLhcpfGb
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @TheLizArmy: @btrfly12 Can someone who is really great at Storify just Storify this tweet chat so I can share that Storify with everyone…
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @AmandaHaddock @c0nc0rdance @TimAllenMDJD We have one liquid biopsy that is FDA approved for detecting a specific mutati…
#LCSM Chat @lcsmchat
RT @jamienholloway: @AmandaHaddock @c0nc0rdance @TimAllenMDJD There is an FDA-approved companion diagnostic in lung cancer. But still, a ne…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @stales: @subatomicdoc great question that I've always wondered about. #CancerSm
Henning Willers, MD, FASTRO @HenningWillers
RT @pfanderson: @HenningWillers @TimAllenMDJD Exactly! Are pathologists accessible to the public? How do you find out who is "your" patholo…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @AshleySumrallMD: @subatomicdoc @TimAllenMDJD And #melanoma. https://t.co/nQG9QlN2ff #cancersm
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
@TimAllenMDJD #cancersm Excellent suggestion!
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: @drjainsp When someone asks me about a new diagnosis, one of the first things I like to do is search for "questions to ask…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @HenningWillers: @JFreemanDaily i have definitely trouble keeping up!! #lcsm #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Closing thoughts as we complete our #cancersm twitterchat this evening?
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: Get your pathology report and usually there's a phone number. If not, your hospital or clinic should be able to provide…
Christina Lizaso @btrfly12
RT @JFreemanDaily: #lungcancer treatments are evolving so fast that even LC specialists have trouble keeping up--dozens of new tx approvals…
Janet Freeman-Daily @JFreemanDaily
@SpiveySandra Most liquid biopsy tests are not yet covered by insurance. However, most test manufacturers can provide some financial assistance. #cancersm
Christina Lizaso @btrfly12
RT @pfanderson: @drjainsp When someone asks me about a new diagnosis, one of the first things I like to do is search for "questions to ask…
Liz Salmi @TheLizArmy
Anyone with cancer ever get to talk to their pathologist... ever? How did you find them? #btsm #cancersm https://t.co/uFr2z4mgD2
Christina Lizaso @btrfly12
RT @JFreemanDaily: @SpiveySandra Most liquid biopsy tests are not yet covered by insurance. However, most test manufacturers can provide s…
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: Closing thoughts as we complete our #cancersm twitterchat this evening?
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @SpiveySandra Most liquid biopsy tests are not yet covered by insurance. However, most test manufacturers can provide s…
Christina Lizaso @btrfly12
RT @TimAllenMDJD: Get your pathology report and usually there's a phone number. If not, your hospital or clinic should be able to provide…
SM RAFIQUL ISLAM @selimshdu
RT @theNCI: T4 A liquid biopsy may also be used to help plan treatment or to find out how well treatment is working or if cancer has come b…
SM RAFIQUL ISLAM @selimshdu
RT @theNCI: T4 A #liquidbiopsy may be used to help find cancer at an early stage. #cancersm
Liz Salmi @TheLizArmy
RT @pfanderson: @HenningWillers @TimAllenMDJD Exactly! Are pathologists accessible to the public? How do you find out who is "your" patholo…
SM RAFIQUL ISLAM @selimshdu
RT @drjainsp: T4 For lung cancers, the minimum testing that must be performed is to look at the EGFR gene for mutations and ALK1 and ROS ge…
Dee Sparacio @womenofteal
Got to run ...#cancersm . Thanks @JFreemanDaily for bringing us all together and @TimAllenMDJD for moderating and everyone who posted. Great Chat! #gyncsm
𝐕𝐚𝐥𝐝𝐚, 𝐉𝐮𝐧𝐠. @soozvjung
RT theNCI: T4 A #liquidbiopsy may be used to help find cancer at an early stage. #cancersm
Henning Willers, MD, FASTRO @HenningWillers
@TimAllenMDJD i am gonna have my next #lungcancer patient try that out😇 #cancersm
SM RAFIQUL ISLAM @selimshdu
RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
@TheLizArmy @btrfly12 @BraveBosom I don't Storify =, but I can get @symplur transcript #Cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
This, #Pathologists! #cancersm
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
Hey @TimAllenMDJD, while we mention biomarkers, I have to mention @ASCO #TAPUR as an awesome example of a clin trial based on biomarkers. Also a great example of multiple clinicians working together. #cancersm https://t.co/UC2C1Da7RO
National Cancer Institute @theNCI
Thank you, everyone, for a fascinating and informative chat! If you have questions about cancer or biomarkers, please reach out to our Cancer Information Service: https://t.co/I0exZMw6s3 If you asked a question tonight, we will try to get you an answer! #cancersm
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
RT @TheLizArmy: Anyone with cancer ever get to talk to their pathologist... ever? How did you find them? #btsm #cancersm https://t.co/z5…
Pub Health Monitor @monitor_PH
RT @theNCI: Thank you, everyone, for a fascinating and informative chat! If you have questions about cancer or biomarkers, please reach out…
Henning Willers, MD, FASTRO @HenningWillers
@TimAllenMDJD learned a lot, fantastic chat #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @HenningWillers: @TimAllenMDJD i am gonna have my next #lungcancer patient try that out😇 #cancersm
Janet Freeman-Daily @JFreemanDaily
Thanks to @TimAllenMDJD for the blog and great job a moderator. And thanks for so much great info from @NCI and so many others! Terrific chat. We'll summarize it on Wakelet in the next several days. #cancersm
@
RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood…
#LCSM Chat @lcsmchat
RT @TheLizArmy: Anyone with cancer ever get to talk to their pathologist... ever? How did you find them? #btsm #cancersm https://t.co/z5…
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
@TimAllenMDJD #cancersm your oncology nurse can help pts access their pathologist
Henning Willers, MD, FASTRO @HenningWillers
RT @TimAllenMDJD: This, #Pathologists! #cancersm https://t.co/NWiANCdndW
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @HenningWillers: @TimAllenMDJD learned a lot, fantastic chat #cancersm
Dennis Keim @denniskeim
@HenningWillers @TimAllenMDJD Exactly. I never thought to contact my pathologist. I presumed my onc and GP were adequate and interpretive points of contact there. #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
It has been my great privilege to participate and my great honor to host tonight's #cancersm twitterchat. My very best to y'all.
Janet Freeman-Daily @JFreemanDaily
RT @TimAllenMDJD: This, #Pathologists! #cancersm https://t.co/NWiANCdndW
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @JFreemanDaily: Thanks to @TimAllenMDJD for the blog and great job a moderator. And thanks for so much great info from @NCI and so many…
#LCSM Chat @lcsmchat
RT @theNCI: Thank you, everyone, for a fascinating and informative chat! If you have questions about cancer or biomarkers, please reach out…
@ok_thej14leroux
RT @theNCI: T4 From NCI’s Cancer Currents blog last year: Liquid biopsy may predict the risk of breast cancer returning years later: https:…
National Cancer Institute @theNCI
RT @JFreemanDaily: Thanks to @TimAllenMDJD for the blog and great job a moderator. And thanks for so much great info from @NCI and so many…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @denniskeim: @HenningWillers @TimAllenMDJD Exactly. I never thought to contact my pathologist. I presumed my onc and GP were adequate an…
#LCSM Chat @lcsmchat
RT @JFreemanDaily: Thanks to @TimAllenMDJD for the blog and great job a moderator. And thanks for so much great info from @NCI and so many…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @DarcyBurbage: @TimAllenMDJD #cancersm your oncology nurse can help pts access their pathologist
#LCSM Chat @lcsmchat
RT @DarcyBurbage: @TimAllenMDJD #cancersm your oncology nurse can help pts access their pathologist
@ok_thej14leroux
RT @theNCI: T4 A liquid biopsy may also be used to help plan treatment or to find out how well treatment is working or if cancer has come b…
#LCSM Chat @lcsmchat
RT @denniskeim: @HenningWillers @TimAllenMDJD Exactly. I never thought to contact my pathologist. I presumed my onc and GP were adequate an…
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: It has been my great privilege to participate and my great honor to host tonight's #cancersm twitterchat. My very best t…
Dennis Keim @denniskeim
RT @JFreemanDaily: #lungcancer treatments are evolving so fast that even LC specialists have trouble keeping up--dozens of new tx approvals…
Christina Lizaso @btrfly12
There's been a lot of discussion from radiologists lately about directly talking to patients. Now the pathologists are in on it too. Love it. #cancersm
Adam L. Booth, MD @ALBoothMD
RT @AshleySumrallMD: @TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as w…
Bob Steele @steele_bob
RT @TimAllenMDJD: It has been my great privilege to participate and my great honor to host tonight's #cancersm twitterchat. My very best t…
Janet Freeman-Daily @JFreemanDaily
RT @pfanderson: @JFreemanDaily @peggyddennis I use the analogies of cherry picking (looking at just the most likely & essential ones to sav…
PF Anderson @pfanderson@disabled.social @pfanderson
RT @israhkhan: #CANCERSM Personalized oncology is based on biomarkers (driver mutations), stage & histology. In lung Ca major biomarkers ar…
Dennis Keim @denniskeim
RT @btrfly12: T5: Second opinions are almost always a good idea - especially in cancer. Seek doc's with high case volume of your specific t…
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @theNCI: Thank you, everyone, for a fascinating and informative chat! If you have questions about cancer or biomarkers, please reach out…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
I love learning from other cancer communities. Together we are stronger. Thanks for organizing this chat @JFreemanDaily #cancersm #MMSM
Janet Freeman-Daily @JFreemanDaily
RT @btrfly12: T5: As @JFreemanDaily bought up, the NCCN guidelines are a great resource and an excellent place for patients to find out wha…
@Cascadia
What % of public or private health insurance covers biomarkers - how can people find a list? @TimAllenMDJD @NCI #CANCERSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @btrfly12: There's been a lot of discussion from radiologists lately about directly talking to patients. Now the pathologists are in on…
Amanda Haddock 🧬 @AmandaHaddock
RT @JFreemanDaily: Thanks to @TimAllenMDJD for the blog and great job a moderator. And thanks for so much great info from @NCI and so many…
Sarika Jain @drjainsp
Excellent discussion, very informative. thank you @TimAllenMDJD #cancersm
Jamie Holloway, PhD @jamienholloway
Can't let a biomarker discussion go by without mentioning the importance of evidence. It's important that any time a drug is suggested based on a biomarker there is data backing that up. #showmethedata #cancersm
Christina Lizaso @btrfly12
Fantastic job! Thanks for all you do and thanks #lcsm for rallying us all together. #cancersm
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
@theNCI Thank you for joining! Thank you @TimAllenMDJD for moderating and to everyone from the wonderful Twittersphere for contributing! #cancersm
Amanda Haddock 🧬 @AmandaHaddock
RT @AshleySumrallMD: Hey @TimAllenMDJD, while we mention biomarkers, I have to mention @ASCO #TAPUR as an awesome example of a clin trial…
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
@TimAllenMDJD Thank you!
Christina Lizaso @btrfly12
RT @DarcyBurbage: @TimAllenMDJD #cancersm your oncology nurse can help pts access their pathologist
Liz Salmi @TheLizArmy
@UppityCancerP @TimAllenMDJD In this age of "meaningful use," where we've had access to: -lab results for a decade -radiology reports for 5 years -clinical notes now for about 12% of the US patients will have easier access to pathology reports into the future. Are pathologists ready to chat? #cancersm
PF Anderson @pfanderson@disabled.social @pfanderson
@MyelomaTeacher @TheLizArmy @btrfly12 @BraveBosom @symplur I will make a Wakelet and tweet it out later tonight. #CancerSM
Amanda Haddock 🧬 @AmandaHaddock
RT @TimAllenMDJD: This, #Pathologists! #cancersm https://t.co/NWiANCdndW
Sandra Spivey @SpiveySandra
@JFreemanDaily Yes $ assistance from test mfgs. For certain income levels and below. If you've saved too much for retirement, you're out of luck. #cancersm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
@JFreemanDaily #LikeABoss #cancersm
Dennis Keim @denniskeim
RT @AshleySumrallMD: Hey @TimAllenMDJD, while we mention biomarkers, I have to mention @ASCO #TAPUR as an awesome example of a clin trial…
Christina Lizaso @btrfly12
RT @theNCI: Thank you, everyone, for a fascinating and informative chat! If you have questions about cancer or biomarkers, please reach out…
Christina Lizaso @btrfly12
RT @AshleySumrallMD: Hey @TimAllenMDJD, while we mention biomarkers, I have to mention @ASCO #TAPUR as an awesome example of a clin trial…
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
Thanks .@TimAllenMDJD #CANCERSM & all who participated! Very informative!
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Absolutely! #cancersm
Regina Garbie @GarbieRegina
RT @theNCI: Thank you, everyone, for a fascinating and informative chat! If you have questions about cancer or biomarkers, please reach out…
Darcy Burbage, DNP, RN, AOCN @DarcyBurbage
RT @jamienholloway: Can't let a biomarker discussion go by without mentioning the importance of evidence. It's important that any time a dr…
Janet Freeman-Daily @JFreemanDaily
Thanks for sharing the link to @NCCN guidelines, @btrfly12! #cancersm #lcsm #btsm #bcsm #mmsm #ayacsm #gyncsm
Liz Salmi @TheLizArmy
@HenningWillers @TimAllenMDJD I just met you Dr. Willers, but I like your style. #cancersm https://t.co/VDAB8zvSrE
Israh Akhtar Khan @israhkhan
@TimAllenMDJD #CANCERSM that was a great discussion, !!!
Christina Lizaso @btrfly12
RT @jamienholloway: Can't let a biomarker discussion go by without mentioning the importance of evidence. It's important that any time a dr…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Thank - you - for your great perspective! #cancersm
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
@pfanderson @TheLizArmy @btrfly12 @BraveBosom @symplur Wakelet?! That's new to me.. :) #Cancersm
Matthew Katz, MD 🇺🇸🟦 @subatomicdoc
Good to see everyone - have a great night! #cancersm
Sandra Spivey @SpiveySandra
@theNCI Will the chat be summarized and posted? #cancersm
Bob Steele @steele_bob
Most excellent Cancer Social Media Twitter chat session tonight. Recognition of expanded commonality of causes bodes well for all. #cancersm
Liz Salmi @TheLizArmy
@TimAllenMDJD Thank you, Dr. Allen, for moderating this really great chat! Thanks to @lcsmchat for bringing the whole community together. On behalf of @BTSMchat and #BTSM, thank you for including your cousins in the brain tumor community. 🙏 #cancersm
Jamie Holloway, PhD @jamienholloway
Awesome biomarker chat tonight at #cancersm! Thanks for hosting @TimAllenMDJD and @lcsmchat!
Peggy Dennis @peggyddennis
@JFreemanDaily @HenningWillers @AshleySumrallMD @TimAllenMDJD Yes and Yes. Interested to hear if same happens if not on targeted for LC. In which case, having broad testing initially would be helpful in regards to new research findings and treatments.
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
2d that @jamienholloway #cancersm
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@TheLizArmy @UppityCancerP @TimAllenMDJD I am nothing w/o my friendly pathologists!
Jen Buhay, PhD 💙 🥥🌴 @JenBuhayPhD
RT @btrfly12: T5: Second opinions are almost always a good idea - especially in cancer. Seek doc's with high case volume of your specific t…
Liz Salmi @TheLizArmy
RT @jamienholloway: Can't let a biomarker discussion go by without mentioning the importance of evidence. It's important that any time a dr…
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @pfanderson: @MyelomaTeacher @TheLizArmy @btrfly12 @BraveBosom @symplur I will make a Wakelet and tweet it out later tonight. #CancerSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
RT @Cascadia: What % of public or private health insurance covers biomarkers - how can people find a list? @TimAllenMDJD @NCI #CANCERSM
someprivate @someprivate
RT @theNCI: T4 A liquid biopsy may also be used to help plan treatment or to find out how well treatment is working or if cancer has come b…
Christina Lizaso @btrfly12
@MyelomaTeacher @pfanderson @TheLizArmy @BraveBosom @symplur I think Storify went away and now is Wakelet. Let's you pull the tweets together and arrange, weed out RTs etc. = Fancy, editable transcript. I did register #cancersm with @healthhashtags so should be available soon.
National Cancer Institute @theNCI
@SpiveySandra Retweeting @JFreemanDaily: Thanks to @TimAllenMDJD for the blog and great job a moderator. And thanks for so much great info from @NCI and so many others! Terrific chat. We'll summarize it on Wakelet in the next several days. #cancersm
Henning Willers, MD, FASTRO @HenningWillers
RT @TheLizArmy: @UppityCancerP @TimAllenMDJD In this age of "meaningful use," where we've had access to: -lab results for a decade -radiolo…
Dennis Keim @denniskeim
RT @drjainsp: T4 There are guidelines for what biomarker testing must be performed on different cancer types. https://t.co/0NmT5EaL4E #canc
PF Anderson @pfanderson@disabled.social @pfanderson
@btrfly12 @MyelomaTeacher @TheLizArmy @BraveBosom @symplur @healthhashtags Storify died after it was bought. Wakelet was a competing product that really beefed up their game, and has been enormously responsive to co-development with users. In many ways, superior to Storify #CancerSM
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Thank you, @theNCI, for your valuable contributions to tonight's #cancersm twitterchat!
National Cancer Institute @theNCI
@subatomicdoc @TimAllenMDJD Good to be with y'all and with so many others. We are all learning together!
Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD
@Cascadia @TimAllenMDJD @NCI Varies based on tumor type. #NGS or next gen seq varies based on platform, company, etc.
Sandra Spivey @SpiveySandra
@UppityCancerP @JFreemanDaily Retired early because I didn't have the energy to work like I did my first 10 years after dx'd with #metastaticbc When I was dx'd with MBC in 1998, I thought about how my husband would spend all of our hard-earned savings after I die and then cry. Good luck w/scans #cancersm
Christina Lizaso @btrfly12
RT @TimAllenMDJD: Thank you, @theNCI, for your valuable contributions to tonight's #cancersm twitterchat! https://t.co/s0HGM7F14R
Janet Freeman-Daily @JFreemanDaily
Transcript for 11-Jul-2019 pancancer chat on "Basics of Biomarker Testing" is here: https://t.co/Y19PJa0dvE #cancersm #lcsm #bcsm #btsm #gyncsm #mmsm
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
#cancersm FTW
National Cancer Institute @theNCI
@TimAllenMDJD You are most welcome. Thank you for moderating and contributing!
@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher
@btrfly12 @pfanderson @TheLizArmy @BraveBosom @symplur @healthhashtags Thanks I just signed on to @symplur and #cancersm wasn't available yet , I hope I remember to check back. Damn chemo-brain if I don't do things right away I forget to do them.
National Cancer Institute @theNCI
RT @JFreemanDaily: Transcript for 11-Jul-2019 pancancer chat on "Basics of Biomarker Testing" is here: https://t.co/Y19PJa0dvE #cancersm #…
Janet Freeman-Daily @JFreemanDaily
@btrfly12 @MyelomaTeacher @pfanderson @TheLizArmy @BraveBosom @symplur @healthhashtags Thanks for registering the hashtag! Transcript for tonight's #cancersm chat is here: https://t.co/Y19PJa0dvE
Timothy Craig Allen, MD, JD, FCAP @TimAllenMDJD
Let's do it again sometime! #cancersm
Lisa (Loehr)Spaulding @leezawilllshe
RT @jamienholloway: T5: Easiest tweetchat answer ever. #cancersm https://t.co/xPHAS32q70 https://t.co/9jxX9jnvIW
#cancersm content from Twitter.